Cellular structure containing small intestinal epithelial cells, method for producing the same, and substrate for retaining the same
A cell culture substrate with defined adhesion and non-adhesion patterns efficiently produces small intestinal epithelial cells with other germ layer derivatives, addressing inefficiencies in existing methods by achieving high yield and suitable structures for drug development and research.
Patent Information
- Application Number
- JP2021068482
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-01-30
- Filing Date
- 2021-04-14
- Publication Date
- 2024-11-07
- Estimated Expiration
- 2040-01-29
AI Technical Summary
Existing methods for producing small intestinal epithelial cells from pluripotent stem cells are inefficient, require long culture periods, and do not yield cell structures suitable for drug development and pathological research due to the lack of integration of cells from multiple germ layers and the use of biological substances.
A cell culture substrate with a specific pattern of cell adhesion and non-adhesion sections is used to culture pluripotent stem cells, allowing for the differentiation of small intestinal epithelial cells along with cells from other germ layers, such as endoderm, ectoderm, and mesoderm, in a shorter culture period and high yield.
The method enables the production of cell structures containing small intestinal epithelial cells with high yield and suitability for drug development and pathological research, facilitating the formation of intestinal organoids with enhanced expression of markers like ABCG2 transporter and CUBN, mimicking intestinal functions.
Smart Images

Figure 0007578951000001 
Figure 0007578951000002 
Figure 0007578951000003
Abstract
Description
[Technical field]
[0001] The present disclosure relates to a cell structure comprising small intestinal epithelial cells and a method for producing a cell structure comprising small intestinal epithelial cells. The present disclosure also relates to a substrate that retains cellular structures including small intestinal epithelial cells. [Background technology]
[0002] Pluripotent stem cells such as embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells) can be induced to differentiate into target cells, and are expected to be applied in the field of regenerative medicine. Methods are being researched to obtain structures called organoids that resemble human tissue by culturing pluripotent stem cells and inducing their differentiation.
[0003] For example, Patent Document 1 describes a method for producing intestinal epithelial organoids from embryonic stem cells.
[0004] Furthermore, as described in Non-Patent Document 2, a technique has been established for inducing non-epithelial cells from organoids by administering TNF-α into the culture medium.
[0005] Another method for inducing differentiation of induced pluripotent stem cells into small intestinal epithelial cells is the method described in Patent Document 2.
[0006] Meanwhile, Patent Document 3 and Non-Patent Document 3 describe a method of inducing differentiation of intestinal tissue by culturing pluripotent stem cells on a substrate on which a pattern of cell adhesion sites has been formed. [Prior art documents] [Patent documents]
[0007] [Patent Document 1] WO2011 / 140441 [Patent Document 2] Patent No. 6296399 [Patent Document 3] Patent No. 6151097 [Patent Document 4] JP 2012-120443 A [Patent Document 5] JP 2013-179910 A [Patent Document 6] Patent No. 5070565 [Non-patent literature]
[0008] [Non-Patent Document 1] Workman et al., Nature Medicine, vol. 23, pp. 49-59, 2017 [Non-Patent Document 2] Hahn et al., Scientific Reports Vol. 7, 2435, 2017 [Non-Patent Document 3] Uchida et al., JCI Insight Vol. 2 e86492 2017 [Non-Patent Document 4] Lee et al., Stem Cell Reports, Vol. 6, pp. 257-272, 2016 [Non-Patent Document 5] Okeyo et al., Tissue Eng Part C, Vol. 21, pp. 1105-1115, 2015 [Non-Patent Document 6] Golos et al., Placenta, Vol. 34, S56-S61, 2013 [Non-Patent Document 7] Chen et al., Biochemical and Biophysical Research Communications, Vol. 436, pp. 677-684, 2013 [Non-Patent Document 8] Kojima et al., Laboratory Investigation, Vol. 97, pp. 1188-1200, 2017 [Non-Patent Document 9] Niwa et al., Nature Genetics, vol. 24, pp. 372-376, 2000 [Non-Patent Document 10] Onozato et al., Drug and Metabolism Disposition Epub ahead of print 2018 [Non-Patent Document 11] Tsunoda et al. Journal of the Japanese Society for Laser Medicine and Surgery, Vol. 28, pp. 355-361, 2008 [Non-Patent Document 12] Mao et al., Pharmaceutical Research, vol. 25, pp. 1244-1255, 2008 [Non-Patent Document 13] Mustata et al., Cell Reports, Vol. 5, pp. 421-432, 2013 [Non-Patent Document 14] Boyd, Placenta, Vol. 27, pp. S24-S26, 2013 [Non-Patent Document 15] Han et al., Expert Opinion on Drug Metabolism & Toxicology, Vol. 14, pp. 817-829, 2018 [Non-Patent Document 16] Kabeya et al., Drug Metabolism and Disposition, Vol. 46, pp. 1411-1419, 2018 [Non-Patent Document 17] Singh et al., Cell Stem Cell Volume 10, pages 312-326 2012 [Non-Patent Document 18] Akutsu et al., Regenerative Therapy, Vol. 1, pp. 18-29, 2015 [Non-Patent Document 19] Okochi et al., Langmuir 25, 6947-6953, 2009 Summary of the Invention [Problem to be solved by the invention]
[0009] The intestine is a complex organ that contains cells derived from three germ layers (endoderm, ectoderm, and mesoderm). The intestine is a complex combination of small intestinal epithelial cells (enterocytes, goblet cells, endocrine cells, brush cells, Paneth cells, M cells, etc.) derived from the endoderm, lymphatic tissue, smooth muscle cells, and interstitial cells of Cajal derived from the mesoderm, and the enteric nerve plexus derived from the ectoderm, and performs functions such as secretion, absorption, and peristalsis.
[0010] The tissue obtained by the method described in Patent Document 1 contains only small intestinal epithelial cells. In addition, because activin is used to induce differentiation from embryonic stem cells, only cells derived from a single germ layer, in this case endoderm-derived cells, are produced. For this reason, in order to obtain intestinal tissue containing other types of cells derived from mesoderm or ectoderm, it was necessary to induce the differentiation of the other types of cells separately, as described in Non-Patent Document 1. In addition, the method described in Patent Document 1 includes a step of embedding and culturing in Matrigel to induce epithelial differentiation, which also poses a problem in productivity.
[0011] The method described in Non-Patent Document 2 also had the problem of laborious cultivation. The tissue obtained by the method described in Patent Document 2 also contains only small intestinal epithelial cells, and therefore has the same problems as the method described in Patent Document 1.
[0012] On the other hand, according to the methods described in Patent Document 3 and Non-Patent Document 3, it is possible to induce differentiation of not only intestinal epithelial tissue but also muscle tissue, nerve tissue, etc., by single culture. This method also has high production efficiency because many intestinal tissues can be cultured simultaneously on one substrate on which many patterns are formed. In addition, since the culture is achieved without using biological substances, it is easily applicable to transplantation purposes.
[0013] However, the methods described in Patent Document 3 and Non-Patent Document 3 require long culture periods and low yields of intestinal tissue, and therefore there is still room for improvement for application to industrial production, which requires uniformity.
[0014] That is, there has been a demand for a means for producing a cell structure containing small intestinal epithelial cells in a relatively short culture period and at a high yield.
[0015] Furthermore, there has been no conventional provision of a cell structure containing small intestinal epithelial cells in a form suitable for use in the development of drugs for preventing or treating intestinal-related diseases or in tests aimed at studying the pathology of intestinal-related diseases. [Means for solving the problem]
[0016] The present disclosure includes the following inventions. (1) A cell culture substrate having a surface including a cell culture portion, The cell culture section includes a cell non-adhesive section and a cell adhesive section that extends continuously or intermittently along the periphery of the cell non-adhesive section and surrounds the cell non-adhesive section. Seeding stem cells onto a cell culture substrate; and A method for producing a cell structure containing small intestinal epithelial cells, comprising culturing the seeded stem cells and differentiating a portion of the stem cells into small intestinal epithelial cells. (2) The method described in (1), wherein the distance between two intersections of a straight line passing through the midpoints of the two most distant points on the inner circumference of the cell adhesion portion that face each other via the non-cell adhesion portion and the inner circumference of the cell adhesion portion is greater than 80 μm and less than 880 μm. (3) The method described in (1) or (2), wherein the width of the cell adhesion portion in a direction along a straight line passing through the midpoints of the two most distant points on the inner circumference of the cell adhesion portion that face each other via the cell non-adhesive portion is more than 30 μm and not more than 400 μm. (4) The method according to any one of (1) to (3), wherein the ratio X' / W' of the distance X' between two intersections of a line passing through the midpoints of the two most distant points on the inner circumference of the cell adhesion portion that face each other via the non-cell adhesion portion and the inner circumference of the cell adhesion portion to the width W' of the cell adhesion portion in the direction along the line passing through the non-cell adhesion portion is preferably 0.5 or more, more preferably 1.0 or more, more preferably 1.3 or more, and is preferably 20.0 or less, more preferably 15.0 or less, more preferably 10.0 or less. (5) The method according to (1), wherein the distance between two intersection points between the periphery of the non-cell-adhesive portion and a line passing through the center of gravity of the non-cell-adhesive portion is greater than 80 μm and less than 880 μm. (6) The method according to (1) or (5), wherein the width of the cell adhesive portion in a direction along a straight line passing through the center of gravity of the cell non-adhesive portion is greater than 30 μm and less than 400 μm. (7) The method according to (1), (5) or (6), wherein the ratio X / W of the distance X between two intersections of the periphery of the non-cell-adhesive portion and a line passing through the center of gravity of the non-cell-adhesive portion to the width W of the cell-adhesive portion in the direction along the line passing through the center of gravity of the non-cell-adhesive portion is preferably 0.5 or more, more preferably 1.0 or more, more preferably 1.3 or more, and is preferably 20.0 or less, more preferably 15.0 or less, more preferably 10.0 or less. (8) a first cell non-adhesive portion; one or more cell culture sections disposed in the first cell non-adhesive section; A cell culture substrate comprising a support substrate having a surface comprising: Each of the one or more cell culture sections includes a central section which is a second cell non-adhesive section, and a cell adhesive section which extends continuously or intermittently along the periphery of the central section and surrounds the central section. Seeding stem cells onto a cell culture substrate; and A method for producing a cell structure containing small intestinal epithelial cells, comprising culturing the seeded stem cells and differentiating a portion of the stem cells into small intestinal epithelial cells. (9) The method described in (8), wherein the distance between two intersections of a straight line passing through the midpoints of the two most distant points opposing each other on the inner circumference of the cell adhesion portion through the central portion and the inner circumference of the cell adhesion portion is greater than 80 μm and less than 880 μm. (10) The method described in (8) or (9), wherein the width of the cell adhesion portion in a direction along a straight line passing through the midpoint between the two most distant points opposing each other on the inner circumference of the cell adhesion portion via the central portion is more than 30 μm and not more than 400 μm. (11) The method according to any one of (8) to (10), wherein the ratio X' / W' of the distance X' between two intersections of a line passing through the midpoint between the two most distant points on the inner circumference of the cell adhesion portion and the inner circumference of the cell adhesion portion to the width W' of the cell adhesion portion in the direction along the line passing through the central portion is preferably 0.5 or more, more preferably 1.0 or more, more preferably 1.3 or more, and is preferably 20.0 or less, more preferably 15.0 or less, more preferably 10.0 or less. (12) The method described in (8), wherein the distance between two intersection points between the periphery of the central portion and a line passing through the center of gravity of the central portion is greater than 80 μm and less than or equal to 880 μm. (13) The method according to (8) or (12), wherein the width of the cell adhesion portion in a direction along a straight line passing through the center of gravity of the central portion is greater than 30 μm and less than 400 μm. (14) The method according to (8), (12) or (13), wherein the ratio X / W of the distance X between two intersections of the periphery of the central portion and a line passing through the center of gravity of the central portion to the width W of the cell adhesion portion in the direction along the line passing through the center of gravity of the central portion is preferably 0.5 or more, more preferably 1.0 or more, more preferably 1.3 or more, and is preferably 20.0 or less, more preferably 15.0 or less, more preferably 10.0 or less. (15) A cell structure comprising small intestinal epithelial cells, A cell structure comprising small intestinal epithelial cells, wherein when the expression levels of the ABCG2 transporter and the ABCB1 transporter in the cell structure are expressed as relative values to the expression levels of the ABCG2 transporter and the ABCB1 transporter in the small intestinal tissue of the animal of origin, respectively, the relative value of the expression level of the ABCG2 transporter in the cell structure is 90 times or more higher than the relative value of the expression level of the ABCB1 transporter. (16) A cell structure comprising small intestinal epithelial cells, A cell structure comprising small intestinal epithelial cells, wherein when the expression levels of CUBN and Villin in the cell structure are expressed as relative values to the expression levels of CUBN and Villin in the small intestinal tissue of the animal of origin, respectively, the relative value of the expression level of CUBN in the cell structure is in the range of 0.2 to 1.8 to the relative value of the expression level of Villin. (17) The cell structure according to (15) or (16), wherein the expression level is based on the amount of mRNA. (18) The cell structure according to any one of (15) to (17), comprising endodermal cells, ectodermal cells and mesodermal cells. (19) A cell culture substrate having a surface including a cell culture portion, The cell culture section includes a cell non-adhesive section and a cell adhesive section that extends continuously or intermittently along the periphery of the cell non-adhesive section and surrounds the cell non-adhesive section. Cell culture substrates, A cell structure containing small intestinal epithelial cells attached on the cell culture section. A cell structure-holding substrate comprising: (20) The cell structure-holding substrate described in (19), wherein the small intestinal epithelial cells are present at least in a position overlapping with the cell adhesion portion when the cell structure-holding substrate is viewed along the normal direction of the surface. (21) When the cell structure-holding substrate is viewed along the normal direction of the surface, the cell structure overlaps with the cell adhesive portion and the cell non-adhesive portion, The cell structure-holding substrate according to (20), wherein the small intestinal epithelial cells are present in greater numbers at positions overlapping with the cell adhesive portions than at positions overlapping with the cell non-adhesive portions. (22) The cell structure-holding substrate according to any one of (19) to (21), wherein the cell structure comprises endodermal cells, ectodermal cells, and mesodermal cells. (23) A cell structure-holding substrate described in any of (19) to (22), in which the distance between two intersections of a straight line passing through the midpoints of the two most distant points opposing each other on the inner circumference of the cell adhesion portion via the non-cell adhesion portion and the inner circumference of the cell adhesion portion is greater than 80 μm and less than 880 μm. (24) A cell structure-holding substrate described in any of (19) to (23), wherein the width of the cell adhesion portion in a direction along a straight line passing through the midpoints of the two most distant points opposing each other on the inner circumference of the cell adhesion portion via the non-cell adhesion portion is greater than 30 μm and less than 400 μm. (25) A cell structure-holding substrate according to any of (19) to (24), wherein the ratio X' / W' of the distance X' between two intersections of a line passing through the midpoints of the two most distant points on the inner circumference of the cell adhesion portion that face each other via the non-cell adhesion portion and the inner circumference of the cell adhesion portion to the width W' of the cell adhesion portion in the direction along the line passing through the non-cell adhesion portion is preferably 0.5 or more, more preferably 1.0 or more, more preferably 1.3 or more, and is preferably 20.0 or less, more preferably 15.0 or less, more preferably 10.0 or less.
[0017] This specification includes the disclosures of Japanese Patent Application No. 2019-014766, which is the priority basis of this application. Effect of the Invention
[0018] According to the method of the present disclosure, a cell structure containing small intestinal epithelial cells can be produced at a high yield in a relatively short culture period.
[0019] The cell structure disclosed herein can be used as an intestinal organoid for the development of drugs for preventing or treating intestinal-related diseases and for pathological research on intestinal-related diseases.
[0020] The cell structure-holding substrate of the present disclosure is easy to handle when using cell structures containing small intestinal epithelial cells in the development of drugs for preventing or treating intestinal-related diseases or in pathological research on intestinal-related diseases. [Brief description of the drawings]
[0021] [Figure 1]Fig. 1 is a schematic diagram of an embodiment of a cell culture substrate having a plurality of annular cell adhesion parts, used in Examples 1 and 8, in which the cell adhesion parts are the exposed surface of a support substrate. Fig. 1(A) is a plan view of the cell culture substrate, and Fig. 1(B) is a schematic cross-sectional view taken along line AA in Fig. 1(A). [Diagram 2] FIG. 2 shows images of cultures on the 1st, 6th, 11th, and 18th days of culture when cultured using each cell culture substrate having annular cell adhesion parts with different inner diameters in Example 1. [Diagram 3] FIG. 3 shows observed images of cultures cultured for 3 weeks using each cell culture substrate having annular cell adhesion parts with different inner diameters in Example 1. [Figure 4] FIG. 4 shows images of tissue having a pouch-like structure that was formed on a substrate having a ring-shaped cell adhesion region with an inner diameter of 380 μm and then detached (the left is a photograph of the entire dish, and the right is an image of the tissue). [Diagram 5] FIG. 5 shows microscopic images of the cultures on the substrates of Comparative Examples 1, 2, and 3, three weeks after the start of culture. [Figure 6] FIG. 6 shows images of cells around one circular cell adhesion site observed on days 4, 9, 13, and 20 of culture in Example 2. [Figure 7] FIG. 7 shows images of cultures on the 1st and 7th days of culture in Example 3 using cell culture substrates with different inner diameters, and images of tissues with pouch-like structures recovered after 3 weeks of culture using a cell culture substrate having a ring-shaped cell adhesion section with an inner diameter of 280 μm. [Figure 8] FIG. 8 shows images of the immunostained culture in Example 4 on the fourth day of culture. [Figure 9] FIG. 9 shows images of immunostained cultures observed on the 7th day of culture in Example 4. [Figure 10] FIG. 10 shows the results of staining with anti-CDX2 antibody, anti-Villin antibody, and DAPI of tissue formed by culturing stem cells on a cell culture substrate having a ring-shaped cell adhesion section with an inner diameter of 280 μm or 380 μm and a width of 60 μm in Example 5. [Figure 11]FIG. 11 shows the results of staining with anti-smooth muscle actin antibody, anti-PGP9.5 antibody, and DAPI of tissues cultured and formed on a cell culture substrate having a ring-shaped cell adhesion section with an inner diameter of 380 μm and a width of 60 μm in Example 5. [Figure 12] FIG. 12 shows images observed on the 18th day of culture on the cell culture substrates having ring-shaped cell adhesion regions of various sizes in Example 6. [Figure 13] FIG. 13 shows the evaluation results of culture on cell culture substrates having ring-shaped cell adhesion portions of various dimensions in Example 6. [Figure 14] FIG. 14 shows an observed image of a tissue having a pouch-like structure obtained by culturing on a cell culture substrate having a ring-shaped cell adhesion part with an inner diameter of 580 μm and a width of 60 μm in Example 6. [Figure 15A] FIG. 15A shows the cell adhesion part used in Example 7, which is a square with inner dimensions of 280 μm to 300 μm on a side and 50 μm to 60 μm in width. [Figure 15B] FIG. 15B shows the cell adhesion section used in Example 7, which is annular with an inner diameter of 280 μm and a width of 60 μm, with 1 / 8 of the circumference missing. [Figure 15C] FIG. 15C shows a cell adhesion section used in Example 7, which has a rectangular shape with inner dimensions of a long side of 600 μm and a short side of 300 μm, and a width of 50 μm. [Figure 15D] FIG. 15D shows a cell adhesion section used in Example 7, which was a square with inner dimensions of 600 μm on a side and 50 μm wide. [Figure 16A] FIG. 16A shows an observed image of a culture in which stem cells were cultured using a cell culture substrate having cell adhesion parts of the shape shown in FIG. 15A. [Figure 16B] FIG. 16B shows an observed image of a culture in which stem cells were cultured using a cell culture substrate having cell adhesion parts of the shape shown in FIG. 15B. [Figure 16C] FIG. 16C shows an observed image of a culture in which stem cells were cultured using a cell culture substrate having cell adhesion parts of the shape shown in FIG. 15C. [Figure 16D]FIG. 16D shows an observed image of a culture in which stem cells were cultured using a cell culture substrate having cell adhesion parts of the shape shown in FIG. 15D. [Figure 17] FIG. 17 shows images of the culture of stem cells cultured on a cell culture substrate having an annular cell adhesion section with an inner diameter of 280 μm or 380 μm and a width of 60 μm in Example 8, observed on the 1st, 7th, and 11th days of culture. [Figure 18] FIG. 18 shows an observed image of tissue having a pouch-like structure obtained by culturing stem cells for three weeks on a cell culture substrate having a ring-shaped cell adhesion section with an inner diameter of 280 μm or 380 μm and a width of 60 μm in Example 8. [Figure 19] FIG. 19 shows the average ABCG2 / ABCB1 ratios in the cell structures obtained on the cell culture substrates under each condition obtained in Example 9. [Figure 20] FIG. 20 shows the average CUBN / Villin ratios in the cell structures obtained on the cell culture substrates under each condition obtained in Example 9. [Figure 21] FIG. 21 shows an immunostained image of cells adhering to a cell adhesion site when Edom iPS stem cells were cultured on a cell culture substrate having a circular cell adhesion site with a diameter of 1500 μm in Example 10. [Figure 22] Figure 22 shows immunostained images of cells adhered to the substrates when Edom iPS stem cells were cultured on each of the cell culture substrates in Example 10: a 3.5 cm diameter cell culture dish (culture dish), a glass substrate without a pattern (both 1.5 cm x 2.5 cm in size) (plain glass), and a substrate with a circular cell adhesion area of 1,500 μm in diameter (patterned substrate). [Diagram 23] FIG. 23 shows an observation image of tissue on the 7th day of culture when Edom iPS cells were cultured on a substrate having a circular cell adhesion part with a diameter of 1500 μm. [Figure 24] Figure 24 shows the expression level of Oct3 / 4 in each sample from the aggregated section and non-aggregated section in Example 11, calculated as a corrected value corrected with the expression level of GAPDH, and shows the relative value of the expression level of Oct3 / 4 in the sample from the aggregated section when the expression level of Oct3 / 4 in the sample from the non-aggregated section is set to 1. [Diagram 25]FIG. 25 shows the results of immunostaining in Example 12. [Figure 26] Fig. 26 is a schematic diagram of an embodiment of a cell culture substrate having a plurality of annular cell adhesion portions, the cell adhesion portions being the surface of a cell adhesion layer. Fig. 26(A) is a plan view of the cell culture substrate, and Fig. 26(B) is a schematic cross-sectional view taken along line AA in Fig. 26(A). [Figure 27] 27 is a photograph showing the results of immunostaining of nerve cells and muscle cells in a culture on day 9 of culture of Edom iPS cells on a cell culture substrate provided with a ring-shaped cell adhesion section with an inner diameter of 600 μm and a width of 100 μm in Example 4. The scale bar indicates 100 μm. [Figure 28] 28 is a photograph showing the results of immunostaining of neurons and intestinal epithelial endoderm cells in a culture on day 9 of culture of Edom iPS cells on a cell culture substrate provided with a ring-shaped cell adhesion section with an inner diameter of 600 μm and a width of 100 μm in Example 4. The scale bar indicates 100 μm. [Figure 29] 29 shows the results of an investigation using the aggregates after one week of culture in Example 13. The scale bar indicates 40 μm. [Diagram 30] 30 shows the results of an investigation using the aggregates after 2 weeks of culture in Example 13. The scale bar indicates 40 μm. [Diagram 31] FIG. 31 shows the results of observation on the fourth day of culture after medium replacement in Example 14. [Diagram 32] FIG. 32 shows the results of observation on the 10th day of culture after medium replacement in Example 14. [Diagram 33] Fig. 33 is a schematic diagram of an embodiment of a cell structure-holding substrate including a cell culture substrate having a non-cell adhesive portion (center portion) and a ring-shaped cell adhesive portion surrounding the non-cell adhesive portion, and a cell structure containing small intestinal epithelial cells, in which the cell structure is present at a position overlapping the cell adhesive portion. Fig. 33(A) is a plan view of the cell structure-holding substrate viewed along the normal direction of the surface S, and Fig. 33(B) is a schematic cross-sectional view taken along line AA in Fig. 33(A). [Diagram 34]Fig. 34 is a schematic diagram of an embodiment of a cell structure-holding substrate including a cell culture substrate having a cell non-adhesive portion (central portion) and a ring-shaped cell adhesive portion surrounding it, and a cell structure including small intestinal epithelial cells, in which the cell structure is present at a position overlapping the cell adhesive portion and the cell non-adhesive portion (central portion). Fig. 34(A) is a plan view of the cell structure-holding substrate viewed along the normal direction of surface S, and Fig. 34(B) is a schematic cross-sectional view taken along line AA in Fig. 34(A). [Diagram 35] Fig. 35 is a schematic diagram of one embodiment of a cell culture substrate having a cell culture section, which includes a non-cell adhesive section (central section) and a cell adhesive section surrounding the periphery of the non-cell adhesive section, on the upper surface of each of a plurality of protrusions. Fig. 35(A) is a plan view of the cell culture substrate, and Fig. 35(B) is a schematic cross-sectional view taken along line AA in Fig. 35(A). [Diagram 36] Fig. 36 is a schematic diagram of one embodiment of a cell culture substrate having a cell culture section, which includes a non-cell adhesive section (central section) and a cell adhesive section surrounding the non-cell adhesive section, on the bottom surface of each of a plurality of recesses. Fig. 36(A) is a plan view of the cell culture substrate, and Fig. 36(B) is a schematic cross-sectional view taken along line AA in Fig. 36(A). [Figure 37] Fig. 37 is a schematic diagram of one embodiment of a cell culture substrate in which a cell culture portion including a non-cell-adhesive portion (center portion) and a cell-adhesive portion surrounding the periphery thereof occupies an entire surface. Fig. 37(A) is a plan view of the cell culture substrate, and Fig. 37(B) is a schematic cross-sectional view taken along line AA in Fig. 37(A). DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0022] <1. Stem cells> The stem cells used in the present disclosure may be any stem cells capable of differentiating into small intestinal epithelial cells, but are preferably stem cells capable of differentiating into endodermal cells (such as small intestinal epithelial cells), ectodermal cells, and mesodermal cells, and are more preferably pluripotent stem cells. As pluripotent stem cells, embryonic stem cells (ES cells) or induced pluripotent stem cells (iPS cells) are particularly preferred.
[0023] The embryonic stem cells (ES cells) used in the present disclosure are preferably mammalian ES cells, and for example, ES cells derived from rodents such as mice or primates such as humans can be used. Particularly preferably, mouse or human ES cells are used. ES cells refer to a stem cell line made from an inner cell mass belonging to a part of an embryo at the blastocyst stage, which is an early stage of animal development, and can be proliferated almost indefinitely in vitro while maintaining the pluripotency to theoretically differentiate into all tissues. As ES cells, for example, cells into which a reporter gene has been introduced near the Pdx1 gene can be used to facilitate confirmation of the degree of differentiation. For example, a 129 / Sv-derived ES cell line in which a LacZ gene has been incorporated into the Pdx1 locus or an ES cell SK7 line having a GFP reporter transgene under the control of the Pdx1 promoter can be used. Alternatively, an ES cell PH3 line having an mRFP1 reporter transgene under the control of an Hnf3β endoderm-specific enhancer fragment and a GFP reporter transgene under the control of the Pdx1 promoter can also be used. In addition, ES cell lines SEES1, SEES2, SEES3, SEES4, SEES5, SEES6 or SEES7 established at the Department of Reproductive and Cellular Medicine, National Center for Child Health and Development and disclosed in Akutsu H, et al. Regen Ther. 2015;1:18-29, or cell lines in which additional genes have been introduced into these ES cell lines can also be used.
[0024] The induced pluripotent stem cells (iPS cells) used in the present disclosure are cells having pluripotency obtained by reprogramming somatic cells. Several groups have succeeded in producing induced pluripotent stem cells, including the group of Professor Shinya Yamanaka et al. at Kyoto University, the group of Rudolf Jaenisch et al. at Massachusetts Institute of Technology, the group of James Thomson et al. at the University of Wisconsin, and the group of Konrad Hochedlinger et al. at Harvard University. For example, International Publication WO2007 / 069666 describes somatic cell nuclear reprogramming factors including gene products of Oct family genes, Klf family genes, and Myc family genes, as well as somatic cell nuclear reprogramming factors including gene products of Oct family genes, Klf family genes, Sox family genes, and Myc family genes, and further describes a method for producing induced pluripotent stem cells by nuclear reprogramming of somatic cells, including a step of contacting somatic cells with the above-mentioned nuclear reprogramming factors.
[0025] The type of somatic cells used to generate iPS cells is not particularly limited, and any somatic cells can be used. That is, the somatic cells referred to in the present disclosure include all cells other than germ cells that constitute the cells of a living body, and may be differentiated somatic cells or undifferentiated stem cells. The origin of the somatic cells is not particularly limited and may be any of mammals, birds, fish, reptiles, and amphibians, but is preferably mammals (e.g., rodents such as mice, or primates such as humans), and is particularly preferably mice or humans. In addition, when human somatic cells are used, any somatic cells from a fetus, a newborn, or an adult may be used. Specific examples of somatic cells include fibroblasts (e.g., skin fibroblasts), epithelial cells (e.g., gastric epithelial cells, hepatic epithelial cells, alveolar epithelial cells), endothelial cells (e.g., blood vessels, lymphatic vessels), nerve cells (e.g., neurons, glial cells), pancreatic cells, blood cells, bone marrow cells, muscle cells (e.g., skeletal muscle cells, smooth muscle cells, cardiac myocytes), hepatic parenchymal cells, non-hepatic parenchymal cells, adipocytes, osteoblasts, cells that constitute periodontal tissue (e.g., periodontal ligament cells, cementoblasts, gingival fibroblasts, osteoblasts), and cells that constitute the kidney, eye, and ear.
[0026] An iPS cell is a stem cell that has the ability to self-replicate over a long period of time under specific culture conditions (e.g., conditions for culturing ES cells) and has the ability to differentiate into ectoderm, mesoderm, and endoderm under specific differentiation-inducing conditions. In addition, the iPS cell in the present disclosure may be a stem cell that has the ability to form a teratoma when transplanted into a test animal such as a mouse.
[0027] To produce iPS cells from somatic cells, first, at least one type of reprogramming gene is introduced into the somatic cells. The reprogramming gene is a gene that encodes a reprogramming factor that has the effect of reprogramming somatic cells to iPS cells. Specific examples of combinations of reprogramming genes include, but are not limited to, the following combinations. (i) Oct gene, Klf gene, Sox gene, Myc gene (ii) Oct gene, Sox gene, NANOG gene, LIN28 gene (iii) Oct gene, Klf gene, Sox gene, Myc gene, hTERT gene, SV40 largeT gene (iv) Oct gene, Klf gene, Sox gene
[0028] <2. Non-cell-adhesive and cell-adhesive areas of cell culture substrate> The cell culture substrate used in the present disclosure has a surface that includes a cell culture portion.
[0029] The cell culture section includes a non-cell-adhesive section, and a cell-adhesive section that extends continuously or intermittently along the periphery of the non-cell-adhesive section and surrounds the non-cell-adhesive section. The cell culture substrate may include one or more cell culture sections on the surface thereof. When two or more cell culture sections are included, each of the cell culture sections may have the above characteristics. The non-cell-adhesive portion in the cell culture section may be referred to as a "second non-cell-adhesive portion" or a "central portion" to distinguish it from a non-cell-adhesive portion (the first non-cell-adhesive portion described below) that exists in a portion other than the cell culture section.
[0030] That is, the cell culture substrate used in the present disclosure has non-cell adhesive portions and cell adhesive portions formed on its surface in a predetermined shape.
[0031] In the following description, in order to explain the characteristics of the cell culture substrate used in the present disclosure other than the cell culture portion including the cell non-adhesive portion and the cell adhesive portion, the portion of the cell culture substrate other than the cell adhesive portion may be referred to as the "support substrate." In other words, the cell culture substrate used in one or more embodiments of the present disclosure can be said to include a support substrate having a surface including one or more cell adhesive portions.
[0032] First, the embodiments of the support substrate and features other than the shapes of the cell non-adhesive portions and the cell adhesive portions will be described below.
[0033] The support substrate used for the cell culture substrate is not particularly limited as long as it is a support substrate formed of a material capable of forming a cell non-adhesive portion and a cell adhesive portion on its surface. Specifically, the support substrate may include inorganic materials such as glass, metal, ceramic, and silicon, and organic materials such as elastomers and plastics (e.g., polystyrene resin, polyester resin, polyethylene resin, polypropylene resin, ABS resin, nylon, acrylic resin, fluororesin, polycarbonate resin, polyurethane resin, methylpentene resin, phenol resin, melamine resin, epoxy resin, and vinyl chloride resin). In particular, it is preferable to use a glass substrate as the support substrate. The shape of the support substrate is not limited, and examples thereof include flat shapes such as flat plates, flat membranes, films, and porous membranes, and three-dimensional shapes such as cylinders, stamps, multi-well plates, and microchannels.
[0034] In the present disclosure, "cell adhesiveness" refers to the strength of adhering cells, i.e., the ease with which cells adhere. A "cell adhesive portion" refers to an area on a surface with good cell adhesiveness, and a "cell non-adhesive portion" refers to an area on a surface with poor cell adhesiveness. Therefore, when cells are seeded on a surface on which cell adhesive portions and cell non-adhesive portions are arranged in a predetermined pattern, the cells adhere to the cell adhesive portions but do not adhere to the cell non-adhesive portions, resulting in the cells being arranged in a pattern on the surface of the cell culture substrate.
[0035] The "cell adhesion portion" is defined as a portion to which cells to be actually cultured, preferably stem cells, adhere when seeded on the cell culture substrate, and the "cell non-adhesive portion" is defined as a portion to which cells to be actually cultured, preferably stem cells, do not adhere when seeded. When seeding cells on the cell culture substrate, the surface of the cell culture substrate may be coated with a protein or the like to enhance cell adhesion. Specific examples of "stem cells" are as described in this specification. The cell non-adhesive portion may be covered by cells that have adhered to and proliferated on the cell adhesion portion.
[0036] The cell adhesion spreading rate during actual cell culture can be used as an index for determining whether a region is a cell adhesion region or a cell non-adhesive region. The surface of a cell adhesion region having cell adhesive properties is preferably a surface with a cell adhesion spreading rate of 60% or more, and more preferably a surface with a cell adhesion spreading rate of 80% or more. A high cell adhesion spreading rate allows cells to be cultured efficiently. The cell adhesion spreading rate in the present disclosure is defined as the spreading rate when the seeding density is 4000 cells / cm 2 More than 30000 cells / cm 2 Cells to be cultured within this range are seeded on the surface to be measured and stored in an incubator at 37°C with a CO2 concentration of 5%. After 14.5 hours of culture, the adhesion rate is defined as the percentage of cells that have attached and spread out ({(number of attached cells) / (number of seeded cells)} x 100(%)).
[0037] In the above measurement, the cells are seeded on the measurement surface by suspending them in DMEM medium containing 10% FBS, and then slowly shaking the measurement surface on which the cells are seeded so that the cells are distributed as uniformly as possible. Furthermore, the cell adhesion spreading rate is measured after replacing the medium immediately before the measurement to remove unadhered cells. In the measurement of the cell adhesion spreading rate, the measurement points are those excluding points where the cell density is likely to be specific (for example, the center of a specified area where the cell density is likely to be high, and the periphery of a specified area where the cell density is likely to be low).
[0038] The cell adhesion portion may be a region where a cell adhesion layer is formed on the surface of the support substrate, or when the surface of the support substrate is cell adhesive (for example, the surface of a glass substrate), it may be a region where the surface of the support substrate is exposed, but is preferably a region where the cell adhesive surface of the support substrate is exposed. The cell non-adhesive portion may be a region where a cell non-adhesive layer is formed on the surface of the support substrate. The cell adhesion portion and the cell non-adhesive portion can be formed by various materials and methods. Preferably, the cell non-adhesive portion is a portion where the surface of the support substrate is covered with a cell non-adhesive layer such as a layer containing a hydrophilic organic compound such as a hydrophilic polymer. As described in Patent Document 4, the average thickness of the cell non-adhesive layer constituting the cell non-adhesive portion is preferably 0.8 nm to 500 μm, more preferably 0.8 nm to 100 μm, more preferably 1 nm to 10 μm, and most preferably 1.5 nm to 1 μm. If the average thickness is 0.8 nm or more, it is preferable because the adsorption of proteins and the adhesion of cells are less affected by the region of the support substrate that is not covered with the cell non-adhesive layer. Also, if the average thickness is 500 μm or less, coating is relatively easy. In particular, as described in Patent Document 5, when the cell non-adhesive layer is formed of a polyethylene glycol layer, the thickness of the layer can be 5 nm to 10 nm. Specific examples of hydrophilic organic compounds are described below.
[0039] As a method for producing a cell culture substrate containing polyethylene glycol (PEG) as a hydrophilic polymer as a non-cell adhesive layer, the methods described in Patent Document 4 and Non-Patent Document 10 can be used.
[0040] Particularly preferred embodiments of the method for forming cell adhesive sites and cell non-adhesive sites include the following two embodiments.
[0041] In the first embodiment, a cell non-adhesive layer is formed on the surface of the support substrate, and then a predetermined treatment is applied to a part of the cell non-adhesive layer to develop cell adhesiveness and form a cell adhesive portion. Specifically, a cell non-adhesive hydrophilic film containing a hydrophilic organic compound such as a hydrophilic polymer is formed on the surface of the support substrate as a cell non-adhesive layer, and then a part of the hydrophilic film, which is the cell non-adhesive layer, is selectively subjected to an oxidation treatment and / or decomposition treatment to modify the part into a cell adhesive portion having cell adhesiveness. In this embodiment, a cell non-adhesive hydrophilic film is formed, and then an oxidation treatment and / or decomposition treatment is applied to the part where cell adhesion is desired, thereby converting the part into a part having cell adhesiveness and forming the cell adhesive portion. In the cell culture substrate formed by the first embodiment, the non-cell-adhesive portion is a portion of the surface of the support substrate covered with a layer containing a hydrophilic organic compound such as a hydrophilic polymer, and the cell-adhesive portion is a portion of the surface of the support substrate exposed after the layer containing a hydrophilic organic compound such as a hydrophilic polymer has been removed by oxidation treatment and / or decomposition treatment, or a portion of the layer containing a hydrophilic organic compound such as a hydrophilic polymer that has been subjected to oxidation treatment and / or decomposition treatment and is covered with a layer (=cell adhesion layer) that has been modified to have cell adhesive properties.
[0042] The second form is a form in which the cell adhesion portion and the cell non-adhesive portion are formed depending on the density of the organic compound on the surface of the support substrate. In the cell culture substrate formed by the second form, the cell adhesion portion is a surface with a low density of hydrophilic organic compounds such as hydrophilic polymers (including the case where no hydrophilic organic compounds are included), and the cell non-adhesive portion is a surface with a high density of hydrophilic organic compounds such as hydrophilic polymers. The second form utilizes the fact that the surface of a support substrate containing a high density of hydrophilic organic compounds such as hydrophilic polymers has cell non-adhesive properties, whereas the surface of a support substrate with a low density of the compounds has cell adhesive properties. When a first region to which the compound is easily bound and a second region to which the compound is not easily bound are provided on the surface of the support substrate, and a film of the compound is formed on the surface of the substrate, the first region becomes a cell non-adhesive portion and the second region becomes a cell adhesive region. Alternatively, a part of the surface of the support substrate is selectively masked with a photoresist or the like, a film of the hydrophilic organic compound is formed on the unmasked region to form a cell non-adhesive portion, and then the masking is removed to expose the surface of the support substrate, thereby forming a cell adhesive portion.
[0043] In addition, the present invention is not limited to the above-mentioned form, and a support substrate having a cell-nonadhesive surface (which may be the surface of a cell-nonadhesive layer) may be prepared, and a part of the surface may be patterned and coated with a cell-adhesive protein such as collagen or fibronectin to form a cell-adhesive pattern. Alternatively, a support substrate having a cell-adhesive surface (which may be the surface of a cell-adhesive layer) may be prepared, and a part of the surface may be coated with a cell-nonadhesive resin such as silicone rubber (e.g., Keiju (registered trademark) manufactured by Mitsubishi Chemical), and the remaining part may be made into a cell-adhesive pattern. Alternatively, a support substrate having a conductive layer of a predetermined pattern on its surface may be prepared, and a cell-nonadhesive layer may be laminated on the surface of the support substrate, and the cell-nonadhesive layer covering the conductive layer may be peeled off by applying a voltage to the conductive layer, and the exposed conductive layer may be made into a cell-adhesive portion (specifically, see JP 2012-120443 A and JP 2013-179910 A).
[0044] Below, we will explain in order the above-mentioned first and second forms, in which cell adhesive portions and non-cell adhesive portions are formed on the surface of a support substrate to produce a cell culture substrate having a surface including cell adhesive portions and non-cell adhesive portions.
[0045] First, the first embodiment will be described. In the first embodiment, a hydrophilic film containing a hydrophilic organic compound, preferably a hydrophilic polymer, is first provided as a cell non-adhesive layer on the surface of a support substrate. The hydrophilic film is a thin film having water-solubility or water-swellability, and is not particularly limited as long as it has cell non-adhesive properties before oxidation and / or decomposition, and the exposed surface of the support substrate after oxidation and / or decomposition, or the surface of the thin film modified by oxidation and / or decomposition, exhibits cell adhesive properties.
[0046] When the cell non-adhesive layer is a hydrophilic film formed by a hydrophilic organic compound, it is preferable to provide a binding layer between the surface of the support substrate and the hydrophilic film as necessary. The binding layer is preferably a layer containing a material having a functional group (binding functional group) capable of binding to the functional group of the organic compound of the hydrophilic film. Examples of combinations of the binding functional group of the material of the binding layer and the functional group of the hydrophilic organic compound include epoxy group and hydroxyl group, phthalic anhydride and hydroxyl group, carboxyl group and N-hydroxysuccinimide, carboxyl group and carbodiimide, amino group and glutaraldehyde, etc. In each combination, either one may be the functional group on the binding layer side. In these methods, before coating with a hydrophilic organic compound, a binding layer is formed on the support substrate by a material having a predetermined functional group. In the cell non-adhesive layer, the water contact angle of the surface of the binding layer before forming a thin film of a hydrophilic organic compound is typically 45° or more, preferably 47° or more, when a silane coupling agent having an epoxy group at its terminal is used as the material having a binding functional group. Such a binding layer can be obtained by forming a coating of a material having a binding functional group on the surface of a supporting substrate.
[0047] Examples of the hydrophilic organic compound include hydrophilic polymers (including hydrophilic oligomers), water-soluble organic compounds, surface active substances, and amphiphilic substances, with hydrophilic polymers being particularly preferred.
[0048] Specific examples of hydrophilic polymers include polyalkylene glycols, zwitterionic polymers having phospholipid polar groups, polyacrylamides, polyacrylic acids, polymethacrylic acids, polyvinyl alcohols, polysaccharides, etc. These specific examples of hydrophilic polymers also include those in the form of derivatives. The molecular shape of the hydrophilic polymer can be linear, branched, dendrimers, etc.
[0049] Specific examples of the polyalkylene glycol include polyethylene glycol, polypropylene glycol, and copolymers of polyethylene glycol and polypropylene glycol, such as Pluronic F108 and Pluronic F127.
[0050] Specific examples of amphoteric polymers having a phospholipid polar group include poly(methacryloyloxyethyl phosphorylcholine) (=MPC polymer), copolymers of methacryloyloxyethyl phosphorylcholine and acrylic monomers, and the like.
[0051] A specific example of polyacrylamide is poly(N-isopropylacrylamide).
[0052] A specific example of polymethacrylic acid is poly(2-hydroxyethyl methacrylate). Specific examples of polysaccharides include dextran and heparin.
[0053] It is desirable that the surface of a support substrate provided with a non-cell-adhesive layer has high cell non-adhesive properties when covered with the non-cell-adhesive layer, and that after oxidation and / or decomposition treatment of the non-cell-adhesive layer, the exposed surface of the support substrate, or the surface of a layer formed by modifying the non-cell-adhesive layer by oxidation and / or decomposition treatment, exhibits cell adhesive properties.
[0054] As the hydrophilic polymer, polyethylene glycol (PEG) is particularly preferred. PEG contains at least an ethylene glycol chain (EG chain) consisting of one or more ethylene glycol units ((CH2)2-O), and may be linear or branched. The ethylene glycol chain is, for example, represented by the following formula: -((CH2)2-O) m - (m is an integer indicating the degree of polymerization) It refers to a structure represented by the following formula: m is preferably an integer of 1 to 13, and more preferably an integer of 1 to 10.
[0055] PEG also includes ethylene glycol oligomers. PEG also includes those into which functional groups have been introduced. Examples of functional groups include epoxy groups, carboxyl groups, N-hydroxysuccinimide groups, carbodiimide groups, amino groups, glutaraldehyde groups, and (meth)acryloyl groups. The functional groups are preferably introduced at the terminals, optionally via a linker. Examples of PEG into which functional groups have been introduced include PEG (meth)acrylate and PEG di(meth)acrylate.
[0056] The cell adhesion portion can be formed by subjecting a non-cell adhesion layer containing a hydrophilic organic compound formed on the surface of the support substrate to an oxidation treatment and / or decomposition treatment to expose the surface of the support substrate having cell adhesive properties, or by modifying the non-cell adhesion layer to convert it into a cell adhesion layer.
[0057] In the present disclosure, the term "oxidation" is used in the narrow sense to mean a reaction in which an organic compound reacts with oxygen to increase the oxygen content compared to before the reaction.
[0058] In this disclosure, "decomposition" refers to a change in which the bonds of an organic compound are broken to produce two or more organic compounds from one type of organic compound. "Decomposition treatment" typically includes, but is not limited to, decomposition by oxidation treatment and decomposition by ultraviolet irradiation. When the "decomposition treatment" is decomposition involving oxidation (i.e., oxidative decomposition), the "decomposition treatment" and the "oxidation treatment" refer to the same treatment. In addition, decomposition and removal of the non-adhesive cell layer is also included in the "decomposition treatment".
[0059] Decomposition by UV irradiation refers to an organic compound absorbing UV light, going through an excited state, and then decomposing. When UV light is irradiated into a system in which an organic compound exists together with molecular species containing oxygen (oxygen, water, etc.), in addition to the UV light being absorbed by the compound and causing decomposition, the molecular species may become activated and react with the organic compound. The latter reaction can be classified as "oxidation." The reaction in which an organic compound is decomposed by oxidation caused by activated molecular species can be classified as "decomposition by oxidation" rather than "decomposition by UV irradiation."
[0060] As described above, the "oxidation treatment" and the "decomposition treatment" may overlap as operations, and it is not possible to clearly distinguish between the two. Therefore, in this specification, the term "oxidation treatment and / or decomposition treatment" is used.
[0061] Next, the second embodiment will be described. In the cell culture substrate formed by the second embodiment, the cell adhesion portion of the surface of the support substrate is a surface having a low density of hydrophilic organic compounds such as hydrophilic polymers (including the case where no hydrophilic organic compounds are contained), and the cell non-adhesion portion is a surface having a high density of hydrophilic organic compounds. That is, the density of the hydrophilic organic compounds differs between the cell adhesion portion and the cell non-adhesion portion. The higher the density, the more difficult it is for cells to adhere. In the cell adhesion portion, the density of the hydrophilic organic compounds is low enough to allow cells to adhere. Preferred examples of the hydrophilic organic compounds and hydrophilic polymers are as described above for the first embodiment.
[0062] In the second embodiment, when the cell adhesion portion and the cell non-adhesion portion are formed by a hydrophilic film with controlled density, it is preferable to form a binding layer on the support substrate as necessary to enhance adhesion to the support substrate, and then form a hydrophilic film made of a hydrophilic organic compound. The binding layer is preferably a layer containing a material containing a functional group (binding functional group) capable of binding to a functional group of the hydrophilic organic compound. Examples of combinations of the functional group of the material of the binding layer and the functional group of the hydrophilic organic compound include epoxy group and hydroxyl group, phthalic anhydride and hydroxyl group, carboxyl group and N-hydroxysuccinimide, carboxyl group and carbodiimide, amino group and glutaraldehyde, etc. In each combination, either one may be the functional group on the binding layer side. In these methods, a binding layer is formed on the support substrate by a material having a predetermined functional group before coating with a hydrophilic material. The density of the material in the binding layer is an important factor that determines the binding force. The density can be easily evaluated using the contact angle of water on the surface of the binding layer as an index. The water contact angle was measured using CA-Z manufactured by Kyowa Interface Science Co., Ltd., 30 seconds after pure water was dropped from a microsyringe.
[0063] The density of the material having a binding functional group in the binding layer of the cell adhesion part is low. In the case where a silane coupling agent having an epoxy group at the end is used as the material having a binding functional group constituting the binding layer, the water contact angle of the surface of the binding layer before forming a thin film of a hydrophilic organic compound in the cell adhesion part is typically 10° to 43°, preferably 15° to 40°. Examples of the method for forming such a binding layer include a method in which a coating (binding layer) of a material having a binding functional group is formed on the surface of a support base material, and then the surface of the binding layer is oxidized and / or decomposed. Examples of the method for oxidizing and / or decomposing the binding layer surface include a method of irradiating the binding layer surface with ultraviolet light, a method of treating with a photocatalyst, and a method of treating with an oxidizing agent. The entire surface of the binding layer may be oxidized and / or decomposed, or may be partially treated. Partial treatment may be performed by using a mask such as a photomask or a stencil mask, or by using a stamp. In addition, the oxidation treatment and / or decomposition treatment may be performed by a direct drawing method such as a method using a laser such as an ultraviolet laser. Regarding the various conditions, the same conditions as those in the method of forming a cell adhesion site by oxidation treatment and / or decomposition treatment of a hydrophilic film can be applied. A thin film of a hydrophilic organic compound can be formed on the binding layer thus formed, thereby forming a cell adhesion site.
[0064] The density of the material having the binding functional group in the binding layer of the cell non-adhesive portion is high. In the case of using a silane coupling agent having an epoxy group at the end as the material having the binding functional group, the water contact angle of the surface of the binding layer before forming the thin film of the hydrophilic organic compound in the cell non-adhesive portion is typically 45° or more, preferably 47° or more. Such a binding layer is obtained by forming a coating of a material having a binding functional group on the surface of the support substrate. When the surface of the binding layer is partially oxidized and / or decomposed, the remaining part that is not treated becomes the binding layer having the water contact angle. A thin film of a hydrophilic organic compound is formed on the binding layer thus formed, thereby forming a cell non-adhesive layer.
[0065] In the second embodiment, a portion of the surface of the support substrate may be selectively masked with a photosensitive photoresist or the like, a film of the hydrophilic organic compound may be formed in the unmasked area to form a non-cell adhesive portion, and then the masking may be removed to expose the surface of the support substrate to form a cell adhesive portion.
[0066] Next, the characteristics of the cell adhesive portions and the cell non-adhesive portions formed in the above first or second embodiment, or by other methods, will be further described.
[0067] The carbon content of the cell adhesion portion (including the binding layer, if present) is preferably lower than the carbon content of the cell non-adhesion portion (including the binding layer, if present). Specifically, the carbon content of the cell adhesion portion is preferably 20-99% of the carbon content of the cell non-adhesion portion. This range is particularly suitable when the thickness of the hydrophilic organic compound layer contained in the cell adhesion portion and the cell non-adhesion portion (the sum of the thickness of the binding layer and the thickness of the hydrophilic film, if present) is 10 μm or less. The "carbon content (atomic concentration, %)" is defined as follows:
[0068] In addition, the percentage (%) of carbon bonded to oxygen in the carbon in the cell adhesion portion (including the binding layer if present) is preferably smaller than the percentage (%) of carbon bonded to oxygen in the carbon in the non-cell adhesion portion (including the binding layer if present). Specifically, the percentage (%) of carbon bonded to oxygen in the carbon in the cell adhesion portion is preferably 35 to 99% of the percentage (%) of carbon bonded to oxygen in the carbon in the non-cell adhesion portion. This range is particularly suitable when the thickness of the hydrophilic film (the sum of the thickness of the binding layer and the thickness of the hydrophilic film if a binding layer is present) is 10 μm or less. The "percentage (atomic concentration, %) of carbon bonded to oxygen" is defined as follows.
[0069] Methods for evaluating the hydrophilic organic compound layer (including the binding layer, if present) contained in the cell adhesion portion and the cell non-adhesion portion include contact angle measurement, ellipsometry, atomic force microscope observation, electron microscope observation, Auger electron spectroscopy, X-ray photoelectron spectroscopy, and various mass spectrometry. Among these methods, X-ray photoelectron spectroscopy (XPS / ESCA) is the most quantitative. This measurement method determines a relative quantitative value, which is generally calculated as an element concentration (atomic concentration, %). The X-ray photoelectron spectroscopy analysis method in the present disclosure will be described in detail below.
[0070] The "carbon amount" of the cell adhesion portion and the cell non-adhesion portion is defined as "the carbon amount obtained from the analysis value of the C1s peak obtained using an X-ray photoelectron spectroscopy device." In addition, in the present disclosure, the "proportion of carbon bonded to oxygen" of the cell adhesion portion and the cell non-adhesion portion is defined as "the proportion of carbon bonded to oxygen obtained from the analysis value of the C1s peak obtained using an X-ray photoelectron spectroscopy device." Specific measurements can be performed as described in JP 2007-312736 A.
[0071] <3. Characteristics of the shape of the cell culture area of the cell culture substrate> The features of the cell culture substrate used in the present disclosure will be described mainly with reference to FIG.
[0072] The cell culture substrate 1 used in the present disclosure is It has a surface S including a cell culture portion 20 .
[0073] The cell culture section 20 includes a cell non-adhesive section (central section) 21, and a cell adhesive section 22 that extends continuously or intermittently along the periphery P of the cell non-adhesive section 21 (FIG. 1 shows an example in which the cell adhesive section 22 extends continuously) and surrounds the cell non-adhesive section 21. This embodiment is an example in which one or more cell culture sections 20 are included on the surface S of the cell culture substrate 1, and each of the one or more cell culture sections 20 has the above-mentioned characteristics.
[0074] In the example shown in FIG. 1, one or more cell culture sections 20 are scattered in an island shape in the cell non-adhesive section 10. In this example, the cell non-adhesive section 10 may be referred to as a "first cell non-adhesive section," and the cell non-adhesive section 21 of the cell adhesive section 20 may be referred to as a "second cell non-adhesive section." In the following description, the "cell non-adhesive section 21" may be referred to as the "central section 21" or the "central section 21 which is a cell non-adhesive section." The first cell non-adhesive section 10 is not an essential component, and an example of a cell culture substrate not provided with the first cell non-adhesive section 10 will be described separately with reference to FIGS. 35 to 37.
[0075] Furthermore, the portion of the cell culture substrate 1 on whose surface the first cell non-adhesive portion 10 and the cell adhesive portion 20 are arranged is referred to as the "support substrate 30."
[0076] In the example shown in Figure 1, the first cell non-adhesive portion 10 and the second cell non-adhesive portion, the central portion 21, are the surfaces of a first cell non-adhesive layer 10A and a second cell non-adhesive layer 21A layered on the surface of the supporting substrate 30.
[0077] 1, the cell adhesion portion 22 is the exposed surface of the support substrate 30. Note that, as in the example shown in Fig. 21, the cell adhesion portion 22 may be the surface of a cell adhesion layer 22A laminated on the surface of the support substrate 30.
[0078] In Figures 1(B) and 21(B), for ease of explanation, the thicknesses of the cell non-adhesive layer 10A, the cell non-adhesive layer 21A, and the cell adhesive layer 22A, as well as the step between the cell adhesive portion 22 and the cell non-adhesive layer 10A or the cell non-adhesive layer 21A, are emphasized; however, the thickness and step are sufficiently small compared to the dimensions of the cells and cell structures to be cultured, so that the surface S including one or more cell culture portions 20 can support cells as a substantially flat surface.
[0079] 1(B) shows an example in which the support substrate 30 is in direct contact with the first non-cell adhesive layer 10A and the second non-cell adhesive layer 21A, but as described above, a bonding layer may be interposed between them. Similarly, FIG. 26(B) shows an example in which the support substrate 30 is in direct contact with the first non-cell adhesive layer 10A, the second non-cell adhesive layer 21A, and the cell adhesive layer 22A, but as described above, a bonding layer may be interposed between them.
[0080] Specific examples and manufacturing methods of the support substrate 30, the first cell non-adhesive portion 10, the first cell non-adhesive layer 10A, the second cell adhesive portion 21, the second cell non-adhesive layer 21A, the cell adhesive portion 22, and the cell adhesive layer 22A are as described above.
[0081] The present inventors have surprisingly found that when stem cells are cultured on a cell culture substrate 1 having such a structure, the stem cells adhere to and grow in the cell adhesion portion 22 surrounding the cell non-adhesive portion (central portion) 21, forming an aggregate portion in which the cells are densely aggregated, and that the formed cell aggregate portion can differentiate into intestinal epithelial cells expressing trophectoderm cell markers, and a bag-like cell structure (tissue) is easily formed. The obtained cell structure contains small intestinal epithelial cells and has the function of an intestinal organoid. The present inventors have found that when stem cells are induced to differentiate using a cell culture substrate having the above structure, the cell structure containing small intestinal epithelial cells can be released and collected from the cell culture substrate in a relatively short time, and the collection efficiency is extremely high.
[0082] The shape and dimensions of the cell culture section 20 are not particularly limited, but in a preferred embodiment, the distance X between the two intersections A1, A2 of the periphery P of the central section 21 and the straight line L passing through the center C of the central section 21 is more than 80 μm and not more than 880 μm, more preferably 180 μm or more and not more than 880 μm, and particularly preferably 180 μm or more and not more than 600 μm. If the distance X is too small, the central section 21 is immediately covered by the trophectoderm cells during proliferation culture, making it difficult to obtain a specific bag-like structure at the outer periphery of the cell structure. On the other hand, if the distance X is too large, it takes a long time for the cells to proliferate and completely cover the central section 21, so the production efficiency of the cell structure decreases. When the distance X is within the above range, the bag-like cell structure can be cultured with high yield in a relatively short time. When the shape of the central section 21 is a circle as shown in FIG. 1 and FIG. 15B, the distance X refers to the diameter of the circle, and when the circle is a perfect circle, the distance X is the same regardless of the straight line L. 15A, 15C, and 15D, when the central portion 21 is rectangular, the distance X is maximum when the straight line L is in the diagonal direction and is minimum when the straight line L is in the short side direction. In the present disclosure, the distance X is preferably within the above range over the entire circumference (i.e., for all straight lines L).
[0083] In another preferred embodiment of the cell culture section 20, the width W of the cell adhesion section 22 in the direction along the straight line L passing through the center of gravity C of the central section 21 is more than 30 μm and not more than 400 μm, more preferably 40 μm or more and not more than 400 μm, and particularly preferably 60 μm or more and not more than 300 μm. If the width W is too small, there is a problem that the cells are easily peeled off during culture. In addition, in order to induce a bag-shaped cell structure, it is desirable for a plurality of cells to adhere to the cell adhesion section 22 in the width direction to form an aggregate section, and for this purpose, a larger width W is preferable, so that the width W is preferably 40 μm or more, and more preferably 60 μm or more, as described above. On the other hand, if the width W is too large, the density of the cells adhered to the cell adhesion section 22 is likely to be biased, making it difficult to form a uniform cell aggregate section in the width direction, and making it difficult to obtain a cell structure with a uniform structure. When the width W is in the above range, the cell structure can be cultured with a high yield in a relatively short time. The width W refers to the width of the cell adhesion portion 22 in the diameter direction of the circle when the shape of the central portion 21 is a circle as shown in Figures 1 and 15B, and when the circle is a perfect circle, the width W is the same no matter what the straight line L is. When the central portion 21 is a rectangle as shown in Figures 15A, 15C, and 15D, the width W is maximum when the straight line L is in the diagonal direction and is minimum when the straight line L is in the short direction. In the present disclosure, the width W is preferably in the above range over the entire circumference (i.e., for all straight lines L).
[0084] In another preferred embodiment of the cell culture section 20, the ratio X / W of the distance X between the two intersections A1, A2 of the periphery P of the central section 21 and the straight line L passing through the center of gravity C of the central section 21 to the width W of the cell adhesion section 22 in the direction along the straight line L is preferably 0.5 or more, more preferably 1.0 or more, more preferably 1.3 or more, and preferably 20.0 or less, more preferably 15.0 or less, more preferably 10.0 or less. When the ratio X / W is within the above range, the cell structure can be cultured with high yield in a relatively short time. In the present disclosure, the ratio X / W is preferably within the above range over the entire circumference (i.e., for all straight lines L).
[0085] Instead of the above-mentioned center of gravity C, distance X, width W, and straight line L, the shape and dimensions of the cell adhesion portion 22 can be defined by the following midpoint C', distance X', width W', and straight line L'. The midpoint C', distance X', width W', and straight line L' will be described with reference to Figs. 15A and 15B. A straight line passing through the midpoint C' between the two most distant points A3 and A4 that face each other on the inner circumference Q of the cell adhesion portion 22 with the central portion 21 in between is defined as a straight line L'. The distance between the two intersections A5 and A6 of this straight line L' and the inner circumference Q of the cell adhesion portion 22 is defined as a distance X'. Also, the width of the cell adhesion portion 22 in the direction along the straight line L' that passes through the midpoint C' is defined as a width W'.
[0086] The distance X' is preferably more than 80 μm and not more than 880 μm, more preferably 180 μm or more and not more than 880 μm, particularly preferably 180 μm or more and not more than 600 μm, particularly preferably 180 μm or more and not more than 500 μm. If the distance X' is too small, the central part 21 is immediately covered by the cells during growth culture, and it is difficult to obtain a specific bag-like structure at the outer periphery of the cell structure. On the other hand, if the distance X' is too large, it takes a long time for the cells to grow and completely cover the central part 21, and the production efficiency of the cell structure decreases. When the distance X' is within the above range, the bag-like cell structure can be cultured with high yield in a relatively short time. When the shape of the central part 21 is a circle as shown in FIG. 1 and FIG. 15B, the distance X' refers to the diameter of the circle, and when the circle is a perfect circle, the distance X' is the same no matter what the straight line L' is. 15A, 15C, and 15D, when the central portion 21 is rectangular, the distance X' is maximum when the straight line L' is in the diagonal direction, and is minimum when the straight line L' is in the short side direction. In the present disclosure, the distance X' is preferably within the above range over the entire circumference (i.e., for all straight lines L').
[0087] The width W' is preferably more than 30 μm and not more than 400 μm, more preferably 40 μm or more and not more than 400 μm, and particularly preferably 60 μm or more and not more than 300 μm. If the width W' is too small, there is a problem that the cells are easily peeled off during culture. In addition, in order to induce a bag-shaped cell structure, it is desirable that a plurality of cells adhere to the cell adhesion part 22 in the width direction to form an aggregate part, and for that purpose, the width W' is preferably larger, so that the width W' is preferably 40 μm or more, and more preferably 60 μm or more, as described above. On the other hand, if the width W' is too large, the density of the cells adhered to the cell adhesion part 22 is likely to be biased, and it is difficult to form a uniform cell aggregate part in the width direction, and it is difficult to obtain a cell structure with a uniform structure. When the width W' is in the above range, the cell structure can be cultured with a high yield in a relatively short time. The width W' refers to the width of the cell adhesion portion 22 in the diameter direction of the circle when the shape of the central portion 21 is a circle as shown in Figures 1 and 15B, and when the circle is a perfect circle, the width W' is the same no matter what the line L' is. When the central portion 21 is a rectangle as shown in Figures 15A, 15C, and 15D, the width W' is maximum when the line L' is in the diagonal direction and is minimum when the line L' is in the short direction. In the present disclosure, the width W' is preferably in the above range over the entire circumference (i.e., for all lines L').
[0088] The ratio X' / W' is preferably 0.5 or more, more preferably 1.0 or more, more preferably 1.3 or more, and preferably 20.0 or less, more preferably 15.0 or less, more preferably 10.0 or less. When the ratio X' / W' is within the above range, the cell structure can be cultured with high yield in a relatively short time. In the present disclosure, the ratio X' / W' is preferably within the above range over the entire circumference (i.e., for all straight lines L').
[0089] In FIG. 1 and FIG. 15B, the central portion 21 is circular, and the cell adhesion portion 22 is annular in shape surrounding the circular central portion 21 concentrically, which is highly symmetrical and is particularly preferable for obtaining a uniform cell structure. However, the present invention is not limited to such an example, and as shown in FIG. 15A, FIG. 15C, and FIG. 15D, the central portion 21 may be rectangular (square or oblong), and the cell adhesion portion 22 may have an inner and outer rectangular shape along the periphery P of the rectangular central portion 21. In addition, although not shown, the central portion may be elliptical, and the cell adhesion portion may have an elliptical annular shape extending along the central portion. In addition, in the above-mentioned examples, the inner and outer contours of the cell adhesion portion are similar in shape, but the present invention is not limited to such an example, and for example, the inner contour of the cell adhesion portion (i.e., the outer contour of the central portion) may be polygonal such as a rectangle, and the outer contour of the cell culture portion may be circular or elliptical, or conversely, the inner contour of the cell adhesion portion (i.e., the outer contour of the central portion) may be circular or elliptical, and the outer contour of the cell culture portion may be polygonal such as a rectangle. The central portion 21 may also be semicircular.
[0090] In the examples of Figs. 1, 15A, 15C, and 15D, the cell adhesion portion 22 extends continuously along the periphery P of the central portion 21, which is the second non-cell adhesion portion, and surrounds the central portion 21 over the entire circumference. However, the cell adhesion portion may have a shape that extends intermittently. Specifically, as shown in the example of Fig. 15B, the cell adhesion portion 22 extends intermittently along the periphery P of the central portion 21, which is the second non-cell adhesion portion, and surrounds the central portion 21. Even in such a structure, the cells that have adhered to the cell adhesion portion 22 can grow and form a tissue that connects the gaps in the cell adhesion portion 22. In an embodiment in which the cell adhesion portion 22 extends intermittently along the periphery P of the central portion 21, each interrupted portion has a length that is preferably less than half, more preferably less than a quarter, more preferably less than a sixth, and more preferably less than an eighth of the total circumference of the periphery P of the central portion 21, and if multiple interrupted portions are included, the total length of the interrupted portions is preferably less than half, more preferably less than a quarter, more preferably less than a sixth, and more preferably less than an eighth of the total circumference of the periphery P of the central portion 21.
[0091] In the cell culture substrate used in the present disclosure, the cell adhesive portion extends so as to surround the non-cell adhesive central portion, so that when cells adhere and proliferate thereon, the cells become dense, which facilitates the promotion of differentiation into cells having the properties of trophectoderm cells, and the proliferated cells are easily layered. As a result, a bag-shaped cell structure can be efficiently obtained in which cells having the properties of trophectoderm cells are distributed on the periphery.
[0092] In contrast, in the methods described in Patent Document 2 and Non-Patent Document 3, since the cell adhesion portion is circular, cells having the properties of trophectoderm cells grow and progress to the inside, making it difficult to obtain a bag-like cell structure in which cells having the properties of trophectoderm cells are distributed on the periphery, and it is difficult to induce differentiation into endodermal cells. This is thought to be the reason for the low recovery rate, as shown in the results of Comparative Example 1 described below. In addition, when the cell adhesion portion is circular, it is thought that it takes time to create an aggregation portion because the area of the cell adhesion portion is large.
[0093] When there are multiple cell culture sections 20, such as the cell culture substrate 1, they are isolated from each other, and are preferably spaced apart by at least 0.20 mm, more preferably at least 0.30 mm. By isolating each cell culture section 20 by at least a certain distance, the cells in each cell culture section 20 are cultured uniformly at a certain interval without forming intercellular bonds with the cells in the adjacent cell culture sections 20, and an experimental system with high reproducibility can be constructed.
[0094] The cell culture substrate 1 according to the embodiment shown in Figures 1, 15A, 15B, 15C, 15D, and 26 has a structure in which one or more cell culture sections 20 are included in a first cell non-adhesive section 10. An embodiment of a cell culture substrate not including a first cell non-adhesive section 10 will be described separately with reference to Figures 35 to 37.
[0095] The differences between the cell culture substrate 1 shown in Figures 35 to 37 and the cell culture substrate 1 shown in Figure 1 or Figure 26 will be described below. The features and method of formation of the cell non-adhesive portion (central portion) 21 and the cell adhesive portion 22 constituting the cell culture section 20 in the cell culture substrate 1 shown in Figures 35 to 37 are similar to the cell non-adhesive portion 21 and the cell adhesive portion 22 in the cell culture substrate 1 shown in Figure 1 or Figure 26, so depictions of the cross-sectional features of the cell non-adhesive portion 21 and the cell adhesive portion 22 in the cross sections of the cell culture substrate 1 in Figures 35(B), 36(B), and 37(B) will be omitted. Other features not mentioned in the cell culture substrate 1 shown in Figures 35 to 37 are similar to the cell culture substrate 1 shown in Figures 1 and 26, so description will be omitted.
[0096] The cell culture substrate 1 according to one embodiment of the present disclosure shown in Figure 35 has a surface S including a cell culture section 20. The cell culture section 20 includes a cell non-adhesive section 21 and a cell adhesive section 22 that extends continuously or intermittently along the periphery P of the cell non-adhesive section 21 (Figure 35 shows an example in which the cell adhesive section 22 extends continuously) and surrounds the cell non-adhesive section 21. In the cell culture substrate 1 shown in Figure 35, the portion on the surface of which the cell adhesive section 20 is arranged is referred to as a "support substrate 30."
[0097] The cell culture substrate 1 shown in Fig. 35 has a support substrate 30 having one or more protrusions 31, and the upper surface S of each protrusion 31 includes a cell non-adhesive portion 21 and a cell adhesive portion 22 surrounding the periphery thereof. In this embodiment, the upper surface S of the protrusion 31 is circular, but may have another shape. In this embodiment, the cell adhesive portion 22 is present on the periphery of the upper surface S of the protrusion 31 in a plan view, and since there is no support substrate outside the cell adhesive portion 22, when cells adhered to the cell adhesive portion 22 are cultured, they do not spread outward from the cell adhesive portion 22, but spread over the cell adhesive portion 22 and the cell non-adhesive portion 21 inside the cell adhesive portion 22 to form a cell structure.
[0098] 35, the cell culture sections 20 (consisting of cell non-adhesive sections 21 and cell adhesive sections 22) are present on the upper surfaces S of the horizontally isolated protrusions 31, so that the cells in each cell culture section 20 are cultured without forming intercellular bonds with the cells in the adjacent cell culture sections 20, making it easy to construct an experimental system with high reproducibility. In this embodiment, when there are multiple protrusions 31, they are preferably spaced apart from each other by 0.20 mm or more, more preferably 0.30 mm or more.
[0099] The cell culture substrate 1 according to one embodiment of the present disclosure shown in Figure 36 has a surface S including a cell culture section 20. The cell culture section 20 includes a cell non-adhesive section 21 and a cell adhesive section 22 that extends continuously or intermittently along the periphery P of the cell non-adhesive section 21 (Figure 36 shows an example in which the cell adhesive section 22 extends continuously) and surrounds the cell non-adhesive section 21. In the cell culture substrate 1 shown in Figure 36, the portion on the surface of which the cell adhesive section 20 is arranged is referred to as a "support substrate 30."
[0100] The cell culture substrate 1 shown in Fig. 36 has a support substrate 30 having one or more recesses 32, and the bottom surface S of each recess 32 includes a cell non-adhesive portion 21 and a cell adhesive portion 22 surrounding the periphery thereof. In this embodiment, the bottom surface S of the recess 32 is circular, but may have another shape. In this embodiment, the cell adhesive portion 22 is present on the periphery of the bottom surface S of the recess 32 in a plan view, and the outside of the cell adhesive portion 22 is the peripheral wall surface of the recess 32. Therefore, when cells adhered to the cell adhesive portion 22 are cultured, they do not spread outward from the cell adhesive portion 22, but spread over the cell adhesive portion 22 and the non-cell adhesive portion 21 inside the cell adhesive portion 22 to form a cell structure.
[0101] 36, cell culture sections 20 (comprising cell non-adhesive sections 21 and cell adhesive sections 22) are present on bottom surfaces S of horizontally separated recesses 32, so that cells in each cell culture section 20 are cultured without forming intercellular bonds with cells in adjacent cell culture sections 20, making it easy to construct an experimental system with high reproducibility. In this embodiment, when multiple recesses 32 are present, they are preferably spaced apart from each other by 0.20 mm or more, more preferably 0.30 mm or more.
[0102] The cell culture substrate 1 according to one embodiment of the present disclosure shown in Figure 37 has a surface S including a cell culture section 20. The cell culture section 20 includes a cell non-adhesive section 21 and a cell adhesive section 22 that extends continuously or intermittently along the periphery P of the cell non-adhesive section 21 (Figure 37 shows an example in which the cell adhesive section 22 extends continuously) and surrounds the cell non-adhesive section 21. In the cell culture substrate 1 shown in Figure 37, the portion on the surface of which the cell adhesive section 20 is arranged is referred to as a "support substrate 30."
[0103] In the cell culture substrate 1 shown in Fig. 37, one cell culture section 20 is formed over the entire flat surface S of the support substrate 30, and the cell adhesion section 22 is disposed on the periphery of the surface S. In this embodiment, the surface S of the support substrate 30 is circular, but may have other shapes. In this embodiment, the cell adhesion section 22 is present on the periphery of the surface S of the support substrate 30 in a plan view, and there is no support substrate outside the cell adhesion section 22. Therefore, when cells adhered to the cell adhesion section 22 are cultured, they do not spread outward beyond the cell adhesion section 22, but spread over the cell adhesion section 22 and the cell non-adhesion section 21 inside it to form a cell structure.
[0104] According to the embodiment shown in Figure 37, only the cell culture section 20 (consisting of a non-cell adhesive section 21 and a cell adhesive section 22) is present in one cell culture substrate 1, so that the cells in the cell culture section 20 are cultured without forming intercellular bonds with other cells, making it easy to construct an experimental system with high reproducibility.
[0105] <4.Cellular structures> The cell constructs produced in the present disclosure include small intestinal epithelial cells. The small intestinal epithelial cells are typically small intestinal epithelial cells that express trophectoderm cell markers.
[0106] The present disclosure is based on the surprising finding that, during cell culture, cells aggregate at high density at cell adhesion parts extending so as to surround cell non-adhesion parts, differentiate into small intestinal epithelial cells expressing trophectoderm cell markers, and a pouch-like cell structure is obtained in which the cells are distributed around the periphery. In the Examples, it has been confirmed that cytokeratin 7, a marker for trophectoderm cells, and CDX2, a marker for small intestinal epithelial cells and trophectoderm cells, are strongly expressed in the cells aggregated at the cell adhesion parts.
[0107] Small intestinal epithelial cells can be identified by the expression of transcription factors CDX2 and HNF4 in the cell nuclei, villin in the villus layer, and the expression of endodermal markers such as E-cadherin. The presence of these markers can be detected by tissue immunostaining using antibodies or PCR evaluation using mRNA.
[0108] The cell structure of the present disclosure contains small intestinal epithelial cells and is useful as an intestinal organoid having a function equivalent to that of the intestine. "Intestinal organoid" refers to a cell structure (tissue) having a function similar to that of the intestine of the cell's origin organism, particularly the intestine of a mammal such as a human, and particularly the human intestine (specifically, the function of peristalsis, mucus secretion, substance absorption, etc.). The cell structure of the present disclosure is useful for the development of drugs for preventing or treating intestinal-related diseases and for pathological research on intestinal-related diseases.
[0109] The overall shape of the cell structure of the present disclosure is not particularly limited, but is usually granular. "Granular" also includes spherical shapes.
[0110] As described in Non-Patent Document 4, it has been shown that mouse ES cells are differentiated into trophectoderm cells when CDX2 is strongly expressed. In this Example, it was also confirmed that the markers CDX2 and Cytokeratin 7 were strongly expressed in the condensation area, and it is considered that the cells are similarly differentiated into cells having the properties of trophectoderm cells.
[0111] Furthermore, it is described in Non-Patent Document 5 that tissues having a pouch-like structure containing CDX2-positive cells can be obtained from human iPS cells. Therefore, in the present disclosure, it is considered possible that stem cells differentiate into CDX2-positive cells in the aggregated areas where cells are densely packed on the cell adhesion areas by culture, and that these cells similarly contribute to the formation of the pouch-like structure.
[0112] Furthermore, Non-Patent Documents 6 to 8 also show that ES cells and iPS cells have the ability to differentiate into trophectoderm cells.
[0113] Based on the above previous findings, and as will be shown later in the present disclosure, a decrease in the Oct3 / 4 gene was observed in cells aggregated at the cell adhesion sites, it is presumed in the present disclosure that stem cells adhere to the cell adhesion sites, proliferate to form aggregation sites, and differentiate from the aggregation sites into small intestinal epithelial cells that express trophectoderm cell markers.
[0114] Non-Patent Document 9 shows that a study using mouse ES cells shows that when expression of the Oct gene is reduced, the cells differentiate into trophectoderm, and it is presumed that similar differentiation occurs in the cell structure disclosed herein.
[0115] In addition, the cell structure induced in the present disclosure is characterized in that the expression of the ABCG2 transporter is equal to or higher than that of the cDNA of the small intestine of the origin animal (if the origin animal is human, the human small intestine). Compared to the intestinal organoids obtained so far, the expression of the ABCG2 transporter is significantly higher.
[0116] In the intestine, the role of ABCG2 transporter is to contribute to intestinal excretion, for example, excretion of uric acid, and its functional decline is thought to cause symptoms such as gout. In order to observe pharmacokinetics, it is necessary to observe not only inhalation but also excretion. Here, there are no particular limitations on the site, sex, age, race, etc., of the small intestine of the source animal, which can be used as a standard for relative values, particularly the cDNA of human small intestine, but the site is preferably the jejunum or ileum, which is the hindgut, and the age is preferably adult age. Various commercially available products can also be used, and they may be obtained from human tissue obtained after receiving informed consent. As a commercially available product of human small intestine cDNA, PCR Ready First Strand cDNA - Human Adult Normal Tissue:Small Intestine (BioChain), or PCR Ready First Strand cDNA-Human Adult Normal Tissue:Ileum (BioChain), which is a product obtained from the ileum to ensure the expression of CUBN, can be used.
[0117] However, the expression of ABCG2 transporters has not been sufficient in the intestinal organoids induced so far. For example, Non-Patent Document 10 is an example of a past analysis, and this also shows expression below that of human intestines. In addition, the expression of ABCG2 transporters in intestinal organoids obtained using human ES cells described in Non-Patent Document 3 was also below that of human intestines. In addition, the values obtained when the previous pattern culture described in Non-Patent Document 2 using iPS cells was performed in the following examples were equivalent to the values obtained with ES cells.
[0118] In addition, Non-Patent Documents 11 and 12 disclose that the ABCG2 transporter is strongly expressed in the placenta, i.e., in trophectoderm cells.
[0119] For example, Non-Patent Document 13 reports that by culturing mouse intestinal tissue, organoid-like tissues can be induced by in vitro culture without using Lgr5-positive intestinal epithelial stem cells as used in Non-Patent Document 1. Here, Trop2-positive cells are expressed in the mouse fetal intestine and are the source of differentiation into organoids. This Trop2 marker is also strongly expressed in trophectoderm cells, and the properties are similar. Therefore, it is believed that the mechanism of development into small intestinal epithelial cells in the present disclosure is similar to this.
[0120] Furthermore, the similarity in properties between trophectoderm cells and small intestinal epithelial cells has also been described in Non-Patent Document 14.
[0121] Therefore, the present disclosure suggests that a similar phenomenon to that described in Non-Patent Document 13 is occurring, and it is believed that small intestinal epithelial cells expressing trophectoderm cell markers are induced to differentiate from trophectoderm cells. Furthermore, because the period of differentiation-inducing culture is short, cell structures (tissues) are obtained in an early stage cellular state, which is likely to result in high expression levels of ABCG2 transporters in the constituent cells.
[0122] The cell structure of the present disclosure further has a relative expression level of the ABCG2 transporter and the ABCB1 transporter in the cell structure, when the expression levels of the ABCG2 transporter and the ABCB1 transporter in the cell structure are expressed as relative values to the expression levels of the ABCG2 transporter and the ABCB1 transporter in the small intestinal tissue of the source animal, respectively, the relative expression level of the ABCG2 transporter in the cell structure is 90 times or more, preferably 100 times or more, relative to the expression level of the ABCB1 transporter. The upper limit of the ratio is not particularly limited, but is, for example, 1000 times or less. The cell structure of the present disclosure is useful as a model of the immature human intestine. For example, Non-Patent Document 15 describes the expression of the ABCB1 transporter and the ABCG2 transporter in the placenta and fetus. According to this, it is described that in the small intestine of a human fetus, the expression level of the ABCB1 transporter is low until 20 weeks after implantation, and becomes as high as that of an adult in the newborn. In contrast, it is described that the expression level of the ABCG2 transporter is as high as that of an adult from 5.5 weeks after implantation. Therefore, it is considered that the expression level of the ABCG2 transporter is higher than that of the ABCB1 transporter in the immature intestine.
[0123] When the animal of origin of the stem cells used to prepare the cell construct is human, human small intestine cDNA that can be used as a standard has already been described.
[0124] Non-Patent Document 16 describes the preparation of intestinal organoids in which the ABCG2 transporter is higher than that in the human intestine by suspension culture. However, this product also has a high expression of the ABCB1 transporter by induction, which is different from the product obtained in this disclosure. In addition, the product described in Non-Patent Document 16 consists of only small intestinal epithelial cells.
[0125] Another method for artificially increasing the expression of a transporter is overexpression by gene transfer, but although this has been achieved in cultured cells, there have been no examples of increasing the expression of a specific transporter in three-dimensional tissues such as organoids or animal intestines. In this respect, the cell structure of the present disclosure is also characterized.
[0126] Methods for measuring the intensity of expression of the ABCG2 transporter and the ABCB1 transporter include genetic methods for measuring mRNA (e.g., qPCR methods such as real-time PCR, or comparison of band densities obtained by agarose gel electrophoresis) and methods for measuring protein expression using antibodies (e.g., flow cytometry), but genetic methods for measuring the amount of mRNA are preferable.
[0127] Here, the reason for defining the expression level of the ABCG2 transporter not solely but as a ratio to the expression level of the ABCB1 transporter is as follows.
[0128] In addition, in the cell structure of the present disclosure, the above transporters are mainly expressed in epithelial cells, but their expression is also observed in interstitial cells. Therefore, if the expression level of a protein (e.g., CDX2 or Villin) expressed only in epithelial cells is used as a standard for the expression level of the ABCG2 transporter, the value will vary depending on the amount of interstitial cells in the cell structure. The above problem can be avoided by evaluating the ratio of the ABCG2 transporter and the ABCB1 transporter, which are both expressed in the cells.
[0129] In addition, cubilin, a protein encoded by the gene CUBN, is a receptor that acts on the absorption of cobalamin (vitamin B12), which is hardly expressed in the duodenum and jejunum but is expressed in the ileum (Jensen et al., Physiological Reports e12086 2014). One embodiment of the cell structure induced in the present disclosure is characterized by a high expression level of CUBN. A cell structure containing small intestinal epithelial cells with a high expression level of CUBN is considered to have at least properties similar to those of the ileum. Since cubilin is expressed in small intestinal epithelial cells, in order to evaluate the expression level of the gene CUBN, it is preferable to evaluate it as a relative value to the expression level of a marker characteristic of small intestinal epithelial cells. Markers characteristic of small intestinal epithelial cells include CDX2, Villin, and Ecadherin, and Villin is preferable.
[0130] Thus, a preferred embodiment of the cell structure of the present disclosure is A cell structure comprising small intestinal epithelial cells, When the expression levels of CUBN and Villin in the cell structure are expressed as relative values to the expression levels of CUBN and Villin in the small intestine tissue of the animal of origin, the relative value of the expression level of CUBN in the cell structure is in the range of 0.2 to 1.8, more preferably 0.24 to 1.72, to the relative value of the expression level of Villin.
[0131] Cellular structures with this characteristic have at least properties similar to those of the ileum.
[0132] When the animal of origin of the stem cells used to prepare the cell construct is human, human small intestine cDNA that can be used as a standard has already been described.
[0133] The cell structure of the present disclosure more preferably contains endodermal cells, ectodermal cells and mesodermal cells.
[0134] The endoderm forms the digestive tract, as well as the tissues of organs such as the lungs, thyroid gland, pancreas, and liver, cells of secretory glands that open into the digestive tract, the peritoneum, pleura, larynx, Eustachian tube, trachea, bronchi, and urinary tract (bladder, most part of the urethra, and part of the ureter). Differentiation of ES cells or iPS cells into endodermal cells can be confirmed by measuring the expression level of endoderm-specific genes. Examples of endoderm-specific genes include AFP, SERPINA1, SST, ISL1, IPF1, IAPP, EOMES, HGF, ALBUMIN, PAX4, and TAT.
[0135] Endodermal cells that may be included in the cell structure of the present disclosure include small intestinal epithelial cells. The intestinal organoid preferably includes one or more selected from intestinal cells, goblet cells, enteroendocrine cells, and Paneth cells as small intestinal epithelial cells, and it is particularly preferable that the small intestinal epithelial cells include all of intestinal cells, goblet cells, enteroendocrine cells, and Paneth cells. The presence of endoderm cells in the cell structure of the present disclosure can be determined based on positive expression of an endoderm cell marker. Examples of intestinal cell markers include CDX2, goblet cell markers include MUC2, enteroendocrine cell markers include CGA, and Paneth cell markers include DEFA6. Other markers for intestinal epithelial cells include ECAD, Na+ / K+-ATPase, and villin. In addition, definitive endoderm markers FOXA2, SOX17, or CXCR4 can also be used as markers for identifying endoderm cells. Furthermore, GATA4, GATA6, or T (Brachyury), which are markers for early endoderm and mesoderm, can also be used as markers for distinguishing endodermal cells.
[0136] The ectoderm forms the epidermis of the skin, the epithelium of the terminal part of the male urethra, hair, nails, skin glands (including mammary glands and sweat glands), sensory organs (including the epithelium of the terminal parts of the oral cavity, pharynx, nose, and rectum, salivary glands), and lenses. Part of the ectoderm invaginates in a groove-like shape during development to form neural tubes, which become the source of neurons and melanocytes of the central nervous system such as the brain and spinal cord. It also forms the peripheral nervous system. Differentiation of ES cells or iPS cells into ectodermal cells can be confirmed by measuring the expression level of genes specific to the ectoderm. Examples of genes specific to the ectoderm include β-TUBLIN, NESTIN, GALANIN, GCM1, GFAP, NEUROD1, OLIG2, SYNAPTPHYSIN, DESMIN, and TH.
[0137] Ectoderm cells that can be contained in the cell structure of the present disclosure include cells that constitute the enteric nerve plexus. The presence of ectoderm cells in the cell structure of the present disclosure can be determined based on positive expression of an ectoderm cell marker. Markers that can be used to distinguish ectoderm cells include the enteric nerve plexus marker PGP9.5 and the neural progenitor cell marker SOX1.
[0138] The mesoderm forms the body cavity and the mesothelium lining it, muscles, skeleton, skin dermis, connective tissue, heart, blood vessels (including vascular endothelium), blood (including blood cells), lymphatic vessels, spleen, kidneys, ureters, and gonads (testes, uterus, and gonadal epithelium). Differentiation of ES cells or iPS cells into mesodermal cells can be confirmed by measuring the expression level of mesoderm-specific genes. Examples of mesoderm-specific genes include FLK-1, COL2A1, FLT1, HBZ, MYF5, MYOD1, RUNX2, and PECAM1.
[0139] Mesodermal cells that can be included in the cell structure of the present disclosure include smooth muscle cells and interstitial cells of Cajal. The presence of mesodermal cells in intestinal organoids can be determined based on positive expression of mesodermal cell markers. As mesodermal cell markers, smooth muscle cell marker α-smooth muscle actin (SMA), and interstitial cell markers of Cajal CD34 and CKIT (in the case of double positivity) can be used. In addition, GATA4, GATA6, or T (Brachyury), which are markers of early endoderm and mesoderm, can also be used as markers for distinguishing mesodermal cells.
[0140] The cell structure of the present disclosure preferably comprises small intestinal epithelial cells on at least a portion of the outer surface. According to this embodiment, the substance on the outside of the cell structure can be absorbed into the inside through the small intestinal epithelial cells on the outer surface, which is preferable. In addition, in this embodiment, when the small intestinal epithelial cells on the outer surface are further transporter positive, it is even more preferable because the uptake of the substance via the transporter is possible. That is, the intestinal organoid containing the transporter-positive small intestinal epithelial cells has a substance absorption ability similar to that of the intestine.
[0141] <5. Method for producing a cell structure containing small intestinal epithelial cells> The method for producing a cell structure comprising small intestinal epithelial cells according to the present disclosure includes the steps of: Seeding stem cells onto a cell culture substrate having the above characteristics; and The method includes culturing the seeded stem cells and differentiating a portion of the stem cells into small intestinal epithelial cells.
[0142] The small intestinal epithelial cells are typically small intestinal epithelial cells that express trophectoderm cell markers.
[0143] The cell culture substrate used in the present disclosure is preferably precoated with a precoat agent for the purpose of promoting adhesion of stem cells to cell adhesion sites. The precoat agent is a component that is applied to the cell culture substrate in advance to promote adhesion of cells to cell adhesion sites. Examples of precoat agents include extracellular matrices (collagen, fibronectin, proteoglycan, laminin, vitronectin), gelatin, lysine, peptides, gel-like matrices containing these, serum, etc. By carrying out the precoat treatment, adhesion of stem cells with low adhesiveness to cell adhesion sites can be promoted, and cell adhesion culture and differentiation induction can be effectively carried out.
[0144] Stem cells can be cultured under conditions that maintain the undifferentiated state before seeding. The medium used for the culture is not particularly limited as long as it does not induce differentiation of stem cells, and examples of the medium include a medium containing leukemia inhibitory factor, which is known to have the property of maintaining the undifferentiated state of mouse embryonic stem cells and mouse induced pluripotent stem cells, and a medium containing basic FGF, which is known to have the property of maintaining the undifferentiated state of human iPS cells.
[0145] The process of culturing stem cells seeded on a cell culture substrate and differentiating a part of the stem cells into small intestinal epithelial cells may be carried out in a medium capable of proliferating and inducing differentiation of the stem cells, and the medium is not particularly limited. Specific examples include the medium used in Patent Document 1, Patent Document 2, and Non-Patent Document 4, and commercially available media such as StemFit (Ajinomoto Co.), StemFlex (Life Technologies), and ReproFF (ReproCell). The medium may be a serum-containing medium, or a serum-free medium containing a known component having properties that can replace serum. It is noted that factors (FGF2, IGF-1, heregulin) contained in Patent Document 1, Patent Document 2, and Non-Patent Document 4 contribute to the proliferation of pluripotent stem cells as described in Non-Patent Documents 17 and 18.
[0146] Examples of media that can be used include MEM medium, BME medium, DMEM medium, DMEM-F12 medium, αMEM medium, IMDM medium, ES medium, DM-160 medium, Fisher medium, F12 medium, WE medium, and RPMI1640 medium. Various growth factors, antibiotics, amino acids, and the like may be added to the medium. For example, 0.1 to 2% pyruvic acid, 0.1 to 2% non-essential amino acids, 0.1 to 2% penicillin / streptomycin, 0.1 to 1% glutamine, 0.1 to 2% β-mercaptoethanol, and 1 mM to 20 mM ROCK inhibitor (e.g., Y27632) may be added.
[0147] The seeding density of stem cells on the cell culture substrate may be according to a conventional method and is not particularly limited. In the present disclosure, the stem cells are seeded at a density of 3×10 4 cells / cm 2 It is preferable to sow at a density of 3 × 10 or more. 4 ~5×10 5 cells / cm 2 It is more preferable to sow at a density of 3 × 10 4 ~2.5×10 5 cells / cm 2 It is even more preferable to sow the seeds at a density of 100-200 μg / ml.
[0148] The incubation temperature is usually 37°C. 2 It is preferable to culture the cells in an atmosphere with a CO2 concentration of about 5% using a cell culture device or the like.
[0149] The culture period after seeding stem cells on the cell culture substrate varies depending on the initial seeding density of the cells and the shape and size of the cell adhesion portion, but is preferably about 2 to 4 weeks. The present inventors have found that when stem cells are cultured and induced to differentiate on a cell culture substrate having the structure described herein, a cell structure containing the differentiated small intestinal epithelial cells is naturally floated and detached and can be recovered 2 to 4 weeks after seeding, and the recovery rate of the cell structure thus recovered is significantly high. The method of the present disclosure is advantageous compared to the method described in Non-Patent Document 3, in which the cell structure is detached after 30 days or more on a substrate having a circular cell adhesion portion, and the recovery rate is very low.
[0150] Furthermore, although the cell structures induced to differentiate by the method disclosed herein will naturally float and detach from the cell culture substrate, detachment of the cell structures from the cell culture substrate may be promoted using various techniques, such as mild enzyme treatment (e.g., Accutase or TrypLE) that does not destroy the cell structures, EDTA treatment, spraying with liquid such as culture medium, or physical detachment using a scraper.
[0151] After the cell structure is detached from the cell culture substrate, the suspension culture may be continued for a further period. The period of suspension culture is not limited.
[0152] The cell structure of the present disclosure in an embodiment having characteristics of immature human small intestine, in which the expression level of ABCG2 transporter is high relative to the expression level of ABCB1 transporter, can be obtained by detaching and recovering the cells 2 to 4 weeks after seeding.
[0153] <6.Cell structure holding substrate> Another aspect of the present disclosure is a method for producing a method for manufacturing a semiconductor device comprising the steps of: A cell culture substrate having a surface including a cell culture portion, The cell culture section includes a cell non-adhesive section and a cell adhesive section that extends continuously or intermittently along the periphery of the cell non-adhesive section and surrounds the cell non-adhesive section. Cell culture substrates, A cell structure containing small intestinal epithelial cells attached on the cell culture section. The present invention relates to a cell structure-holding substrate comprising:
[0154] The cell structure-holding substrate holds the cell structure containing small intestinal epithelial cells on the substrate, and therefore the cell structure containing small intestinal epithelial cells is easy to handle when used in tests for the development of drugs for preventing or treating intestinal-related diseases or for the purpose of studying the pathology of intestinal-related diseases. The cell structure-holding substrate can also be used as a scaffold for culturing viruses or microorganisms that grow in small intestinal tissue, such as norovirus.
[0155] It is also possible to continue culturing the cell structure on the cell structure-holding substrate in a medium for culturing the cell structure containing small intestinal epithelial cells as described above, thereby maturing the cell structure containing small intestinal epithelial cells, and then releasing and recovering the cell structure from the cell culture substrate.
[0156] The proliferation rate of the cells that constitute the cell structure is higher when the cell structure is adhered to a cell culture substrate than when the cell structure is suspended in the medium, and therefore the cell structure-holding substrate of the present disclosure is suitable for the above-mentioned applications.
[0157] In addition, the cell structure adheres to the cell culture substrate in a state in which the cells have progressed and spread out. Therefore, the cell structure-holding substrate of the present disclosure is suitable as a scaffold for culturing viruses or microorganisms that grow in small intestinal tissue.
[0158] The cell structure-holding substrate is preferably in contact with a buffer solution or medium so that the cell structure can survive.
[0159] One embodiment of the cell structure-holding substrate will be described with reference to FIG. 33, and another embodiment will be described with reference to FIG.
[0160] A cell structure-holding substrate 100 according to the embodiment shown in FIG. 33 includes a cell culture substrate 1 and a cell structure 101 containing small intestinal epithelial cells.
[0161] The cell culture substrate 1 has a surface S including a cell culture section 20. The cell culture section 20 includes a cell non-adhesive section (central section) 21 and a cell adhesive section 22 that extends continuously or intermittently along the periphery P of the cell non-adhesive section 21 (FIG. 33 shows an example in which the cell non-adhesive section 22 extends continuously) and surrounds the cell non-adhesive section 21. In the example shown in FIG. 33, the surface S further includes a first cell non-adhesive section 10, and one or more cell culture sections 20 are arranged in the first cell non-adhesive section 10. The portion of the cell culture substrate 1 on which the first cell non-adhesive section 10 and the cell adhesive section 20 are arranged is referred to as a "support substrate 30."
[0162] The characteristics of the cell culture substrate and the method of manufacturing the same are as described herein, particularly in <2. Cell non-adhesive portion and cell adhesive portion of the cell culture substrate> and <3. Characteristics of the shape of the cell culture portion of the cell culture substrate>, and therefore further description will be omitted. Since the thicknesses of and / or the steps between the first cell non-adhesive portion 10, the second cell non-adhesive portion (central portion) 21, and the cell adhesive portion 22 are sufficiently small relative to the dimensions of the cell structure 101, the surface S of the support substrate 30, including the first cell non-adhesive portion 10, the second cell non-adhesive portion (central portion) 21, and the cell adhesive portion 22, is shown as a flat plane in Fig. 33(B).
[0163] In the cell structure-holding substrate 100 according to the embodiment shown in FIG. 33, the cell structure 101 including the small intestinal epithelial cells is present at a position overlapping at least the cell adhesion portion 22 when the cell structure-holding substrate 100 is viewed along the normal direction of the surface S. When stem cells are seeded on the cell culture substrate 1 and cell culture is performed, the stem cells adhere to the cell adhesion portion 22 and grow, forming an aggregation portion in which the cells are densely aggregated. Then, the cells in the aggregation portion differentiate into small intestinal epithelial cells expressing a trophectoderm cell marker in the formed cell aggregation portion, forming the cell structure 101 shown in FIG. 33. The small intestinal epithelial cells present at a position overlapping with the cell adhesion portion 22 when the cell structure-holding substrate 100 is viewed along the normal direction of the surface S are preferably cells expressing one or more markers selected from CDX2, cytokeratin 7, and E-cadherin.
[0164] The cell structure-holding substrate 100 according to the embodiment shown in Fig. 34 comprises a cell culture substrate 1 and a cell structure 101 containing small intestinal epithelial cells, and the cell structure 101 containing small intestinal epithelial cells is located at a position overlapping with the cell adhesive portion 22 and the cell non-adhesive portion (central portion) 21 when the cell structure-holding substrate 100 is viewed along the normal direction of the surface S. In this embodiment, the features of the cell culture substrate 1 are similar to those of the embodiment shown in Fig. 33, and therefore description thereof will be omitted. In Fig. 34(B) as well, the surface S of the support substrate 30, including the first cell non-adhesive portion 10, the second cell non-adhesive portion (central portion) 21, and the cell adhesive portion 22, is shown as a flat plane.
[0165] When stem cells are seeded on the cell culture substrate 1 and cell culture is performed, the stem cells adhere to the cell adhesion portion 22 and grow, forming an aggregation portion where the cells are densely aggregated, and the cell adhesion portion 22 is covered with a cell structure 101 containing small intestinal epithelial cells, as shown in Figure 33. When the culture is continued further, the cell non-adhesive portion (center portion) 21 is covered by cells that have migrated from the cell structure 101 on the cell adhesion portion 22, and the cell structure 101 that covers the cell non-adhesive portion (center portion) 21 and the cell adhesion portion 22 is formed.
[0166] 34, when the cell structure-holding substrate 100 is viewed along the normal direction of the surface S, the cell structure 101 preferably contains more small intestinal epithelial cells at a position 101a overlapping with the cell adhesive portion 22 than at a position 101b overlapping with the cell non-adhesive portion (central portion) 21. This can be confirmed by immunostaining and observing the cell structure 101 adhered to the cell culture substrate 1 using an antibody against a marker for small intestinal epithelial cells (for example, one or more markers selected from CDX2, cytokeratin 7, and E-cadherin). Furthermore, when the cell structure-holding substrate 100 is viewed along the normal direction of the surface S, the amount of mRNA of a marker for small intestinal epithelial cells in the mRNA of a cell sample collected from position 101a that overlaps with the cell adhesion portion 22 of the cell structure 101 is compared with the amount of mRNA of a marker for small intestinal epithelial cells in the mRNA of a cell sample collected from position 101b that overlaps with the cell non-adhesive portion (central portion) 21 of the cell structure 101; if the former is greater than the latter, it can be determined that the cell structure 101 contains more small intestinal epithelial cells at position 101a that overlaps with the cell adhesion portion 22 than at position 101b that overlaps with the cell non-adhesive portion (central portion) 21 when the cell structure-holding substrate 100 is viewed along the normal direction of the surface S.
[0167] The cell structure 101 in the embodiment shown in Figure 34 preferably contains nerve cells and muscle cells at position 101b overlapping with the cell non-adhesive portion (central portion) 21 when the cell structure-holding substrate 100 is viewed along the normal direction of the surface S, and more preferably contains more nerve cells and muscle cells at position 101b overlapping with the cell non-adhesive portion (central portion) 21 than at position 101a overlapping with the cell adhesive portion 22.
[0168] Another preferred example of the cell structure 101 in the embodiment shown in Figure 34 preferably contains endodermal cells (including small intestinal epithelial cells), ectodermal cells and mesodermal cells, preferably has a bag-like structure, and more preferably has the characteristics described above in <4. Cell structure>.
[0169] The cell structure-holding substrate according to one or more embodiments of the present disclosure can be produced by seeding and culturing stem cells on the surface of a cell culture substrate. Preferred aspects of the stem cells and culture conditions are as described above in <1. Stem cells> and <5. Method for producing a cell structure containing small intestinal epithelial cells>. However, for the purpose of producing a cell structure-holding substrate, it is preferable to expose the cell culture substrate to conditions that make it difficult for the culture and maturation of the cell structure to proceed after the cell structure adhered to the cell culture portion of the cell culture substrate reaches a desired stage before it is detached from the cell culture substrate, thereby producing a cell structure-holding substrate product.
[0170] The above-mentioned "conditions that make it difficult for the culture and maturation of cell structures to proceed" include low temperature conditions and conditions in a medium or buffer that does not contain nutritional factors or contains them at low concentrations.
[0171] Hereinafter, the present disclosure will be described with reference to specific experimental results, but the scope of the present disclosure is not limited to the scope of the experimental results. EXAMPLES
[0172] <Example 1> (Preparation of cell culture substrate) As a cell culture substrate, a cell culture substrate was prepared, which includes a cell adhesion portion (see FIG. 1) consisting of a circular pattern with an inner diameter of 180 μm, 280 μm, or 380 μm and a width of 60 μm, which is a region formed by oxidative decomposition of a layer of polyethylene glycol 400 formed on a glass substrate, and a cell non-adhesive portion, which is a region in which the surface of the glass substrate is coated with polyethylene glycol 400 inside and outside the circular pattern of the cell adhesion portion. The cell culture substrate includes a plurality of cell adhesion portions consisting of the circular patterns formed at intervals of 300 to 500 μm (see FIG. 1). In the following description, the cell adhesion portion consisting of a circular pattern is referred to as an "annular cell adhesion portion."
[0173] The cell culture substrate was prepared according to the procedures described in Japanese Patent No. 5070565 (Patent Document 6) and Okochi et al., Langmuir, Vol. 25, pp. 6947-6953, 2009 (Non-Patent Document 19). An outline of the procedure is given below.
[0174] (First stage reaction) 39.0g of toluene, 0.48g of epoxy silane TSL8350 (GE Toshiba Silicone), and 0.97g of triethylamine were mixed and stirred at room temperature for 10 minutes. A 10cm square glass substrate that had been UV-cleaned was immersed in this silane solution with the cleaned surface facing upwards. After leaving it at room temperature for 16 hours, the substrate was washed with ethanol and water and dried with a nitrogen blower. This resulted in the formation of a thin film containing epoxy groups on the surface of the glass substrate.
[0175] (Second stage reaction) 25μl of concentrated sulfuric acid was added drop by drop to 50g of polyethylene glycol (PEG400) with an average molecular weight of 400 while stirring. After stirring for several minutes, the entire amount was transferred to a glass dish. The above substrate was immersed in the mixture and reacted at 80℃ for 20 minutes. After the reaction, the substrate was thoroughly washed with water and dried with nitrogen blow. This resulted in the formation of a uniform hydrophilic thin film on the glass surface.
[0176] (Oxidation treatment) A photomask was prepared by coating the entire surface with a titanium oxide photocatalyst. The photomask used was a 5-inch size photomask with multiple openings formed at intervals of 300 to 500 μm in shape corresponding to the annular cell adhesion parts of the above dimensions, and with openings of approximately 1.5 cm in width around the periphery. The illuminance of the exposure machine was measured in advance at a wavelength of 350 nm to serve as a guide for setting the exposure time. The photocatalyst layer of this photomask was brought into contact with the hydrophilic thin film on the surface of the substrate, and the substrate was placed in the exposure machine so that light was irradiated from the photomask side. The illuminance at a wavelength of 350 nm was 20 mW / cm 2The substrate was exposed to a mercury lamp for 50 seconds to partially decompose the hydrophilic thin film on the substrate surface by oxidation. The substrate was cut into pieces measuring 25 mm x 15 mm and used as a cell adhesion substrate. Before use in cell culture, the cell culture substrate was sterilized with EOG for 22 hours.
[0177] The cell culture substrate was placed on the bottom of a 3.5 cm Petri dish (Corning) and coated with vitronectin (Life Technologies) diluted 1 / 100 in phosphate-buffered saline (PBS) at room temperature for 30 minutes or more, and then washed three times with PBS before use. The cell culture substrate thus obtained has a cross-sectional structure as shown in FIG. 1(B).
[0178] (culture) The National Center for Child Health and Development (NCHD) has established a human iPS cell line, Edom iPS cells, by transiently expressing the four Yamanaka factors in cells obtained from menstrual blood using a Sendai virus vector (PLoS Genet. 2011 May; 7(5): e1002085. Published online 2011 May 26. doi: 10.1371 / journal.pgen.1002085PMCID: PMC3102737). Edom iPS cells were pre-grown in vitronectin-coated cell culture dishes (Corning) using StemFit medium (Ajinomoto). The grown cells were detached from the dishes by treating them with EDTA (Invitrogen) diluted 1 / 1000 in PBS at 37°C for 10 minutes, and 1 × 10 cells were plated on the cell culture substrate. 6 The cells were seeded and cultured. The XF hESC medium described in Non-Patent Document 3 was used as the medium. On the day of seeding, the medium contained Y27632, but the medium was replaced the next day and the cells were maintained in the medium without Y27632. From the fourth day onwards, the medium was replaced once every 3 to 4 days. During the culture, tissues that had naturally detached from the cell culture substrate were collected and maintained in suspension culture in the same medium in a separate Petri dish.
[0179] Figure 2 shows images of cultures on days 1, 6, 11, and 18 of culture when cultured using cell culture substrates with ring-shaped cell adhesion regions of different inner diameters. The image on day 1 of culture is magnified at a higher magnification than the other images. It was observed that cells first proliferated at the ring-shaped cell adhesion regions, and then the inner non-cell adhesion regions surrounded by the ring-shaped cell adhesion regions were covered by the proliferated cells.
[0180] Observation images of the cultures after 3 weeks of culture are shown in Figure 3. The observation images shown in Figure 3 show that tissues having pouch-like structures were formed at a high rate by culture on each cell culture substrate.
[0181] As a result of this culture, it was shown that the tissue having a pouch-like structure can be naturally detached from the surface and collected 2 to 3 weeks after the start of culture. Figure 4 shows an observation image of the tissue having a pouch-like structure formed and detached on a substrate having a ring-shaped cell adhesion part with an inner diameter of 380 μm (left: a photograph of the entire dish, right: an observation image of the tissue). In the left photograph of Figure 4, the white dots visible in the dish are the tissue having a pouch-like structure. The right photograph of Figure 4 is a microscopic observation image of the tissue having a pouch-like structure obtained in this example. The observation image of the tissue having a pouch-like structure obtained in this example is similar to the observation image of the pouch-like tissue (intestinal organoid) having intestinal function described in Uchida et al., JCI Insight Vol. 2 e86492 2017 obtained by culturing iPS cells in a similar medium, and from the results of Examples 4 and 5 described later, it can be seen that the tissue having a pouch-like structure obtained in this example is also an intestinal organoid.
[0182] The ratio of recovered tissue having a pouch-like structure to the number of circular cell adhesion sites on the cell culture substrate (hereinafter sometimes referred to as the "tissue recovery rate") was 80% or more, which was a high yield.
[0183] <Comparative Examples 1 to 3> As Comparative Example 1, a cell culture substrate was prepared, which had a cell non-adhesive area, which is an area covered with a polyethylene glycol layer, and multiple circular cell adhesive areas with a diameter of 1,500 μm formed by oxidative decomposition of the polyethylene glycol layer, as described in Uchida et al., JCI Insight Vol. 2 e86492, 2017.
[0184] As Comparative Example 2, a cell culture substrate was prepared that had the same structure as Comparative Example 1, except that each of the plurality of circular cell adhesion sites had a diameter of 282 μm.
[0185] The methods for producing the cell culture substrates of Comparative Examples 1 and 2 were the same as those for producing the cell culture substrate of Example 1, and the shape of the openings in the photomask may be appropriately changed depending on the cell adhesion portions. As Comparative Example 3, a glass substrate on which no adhesive pattern was formed was prepared.
[0186] On each of the substrates of Comparative Examples 1 to 3, Edom iPS cells were seeded and cultured under the same conditions as in Example 1.
[0187] FIG. 5 shows microscopic images of the cultures on the substrates of Comparative Examples 1, 2, and 3, three weeks after the start of culture.
[0188] In Comparative Example 1, the start of detachment of the tissue having a pouch-like structure from the surface was observed 3 to 4 weeks after the start of culture, and the tissue recovery rate was 4 to 5%. Compared with Example 1, the culture period until detachment was longer in Comparative Example 1, and the tissue recovery rate was lower.
[0189] In Comparative Example 2, tissues having a pouch-like structure were obtained 2 to 3 weeks after the start of culture, but many cell aggregates with dark observation images were obtained. The tissue recovery rate of tissues having a pouch-like structure was 10% or less. In addition, as shown by the arrow in "Comparative Example 2" in Figure 5, tissues having a large pouch-like structure were sometimes formed by the fusion of cultures in multiple adjacent circular patterns.
[0190] In Comparative Example 3, one or two small pouch-like structures were obtained in some cases, but cell proliferation was necessary over the entire surface of the substrate until tissues having pouch-like structures were formed, and culture took more than one month, and the number of tissues having pouch-like structures formed was significantly smaller than in Example 1. Note that, because the number of patterns of the cell adhesion part was not determined, the tissue recovery rate could not be calculated in this case.
[0191] The above results show that by culturing iPS cells on a substrate having multiple cell adhesion sites consisting of a circular pattern, as in Example 1, tissues having a pouch-like structure can be obtained in a short culture period, and the tissue improvement rate is significantly high.
[0192] <Example 2> In order to observe the progress of the pattern culture in Example 1, the following time-lapse observation was carried out.
[0193] A cell culture substrate having multiple annular cell adhesion sites with an inner diameter of 380 μm and a width of 60 μm, as used in Example 1, was fixed to the bottom surface of a dish to produce a device. Using this device, Edom iPS cells were seeded and cultured under the same conditions as in Example 1.
[0194] Photographs were taken using a BioStation (Nikon) every 12 hours from day 4 to day 21 of culture. Photographs were taken according to the attached manual, and the medium was changed once every 2 to 3 days.
[0195] Figure 6 shows images of cells around one circular cell adhesion site on days 4, 9, 13, and 20 of culture. It was confirmed that the cells first proliferated and layered on the circular pattern, and then formed a pouch-like structure by day 21 of culture.
[0196] <Example 3> We attempted to form tissue with pouch-like structures using other cell types. The human ES cell line SEES2 was cultured using a cell culture substrate with an inner diameter of 180 μm, 280 μm, or 380 μm and a ring-shaped cell adhesion part with a width of 60 μm, as in Example 1. First, the cells were cultured and proliferated in a vitronectin-coated cell culture dish (Corning) using StemFit medium (Ajinomoto Co.) supplemented with rhLIF (Wako Pure Chemical Industries, Ltd.) diluted at 1 / 1000. The cultured cells were detached and collected by treatment with Accutase (Life Technologies) at 37° C. for 5 minutes, seeded on the substrate, and cultured in the same manner as in Example 1.
[0197] 7 shows images of the tissue with a pouch-like structure recovered after 3 weeks of culture using a cell culture substrate with a ring-shaped cell adhesion part with an inner diameter of 280 μm. The images of the tissue with a pouch-like structure and the tissue recovery rate were similar to those in Example 1 using iPS cells.
[0198] These results indicate that tissues having a pouch-like structure can be efficiently produced by culturing stem cells on a cell culture substrate containing annular cell adhesion sites, and that the formation of such tissues occurs when ES cells are used in the same way as when iPS cells are used as in Example 1, regardless of the type of pluripotent stem cells.
[0199] <Example 4> To examine the culture process in Example 1, cells were cultured on a cell culture substrate having a ring-shaped cell adhesion part with an inner diameter of 380 μm and a width of 60 μm, the same as in Example 1, and the expression of markers was examined by immunostaining.
[0200] The cell culture substrate having a ring-shaped cell adhesion portion with an inner diameter of 380 μm and a width of 60 μm and the cell culture conditions are as described in Example 1.
[0201] Cell culture substrates containing tissues on the 4th, 7th, or 12th to 14th day of culture were fixed with 4% paraformaldehyde (Wako Pure Chemical Industries, Ltd.) at room temperature for 20 minutes, washed with PBS, and blocked with 1% BSA and 0.1% Triton-containing PBS at room temperature for 30 minutes. The substrates were then incubated with mouse IgG1-labeled anti-Cytokeratin7 antibody (Abcam, dilution rate 1 / 500), mouse IgG3b-labeled anti-Oct3 / 4 antibody (SantaCruz Biotechnologies, dilution rate 1 / 200), rabbit IgG-labeled anti-Ki67 antibody (Abcam, dilution rate 1 / 500), or rabbit IgG-labeled anti-CDX2 antibody (Abcam, dilution rate 1 / 1000) at room temperature for 1 hour. After incubation, the substrate was washed three times with PBS, and then incubated with Alexa488-labeled anti-rabbit IgG antibody (Molecular Probes, dilution rate 1 / 1000) or Alexa546-labeled anti-mouse IgG antibody (Molecular Probes, dilution rate 1 / 1000) diluted with PBS at room temperature for 30 minutes. After incubation, the substrate was further washed three times with PBS, and then the cell nuclei of the cells on the substrate were stained with DAPI (Sigma, dilution rate 1 / 1000) at room temperature for 10 minutes, then sealed and observed under a confocal microscope. The types of antibodies were appropriately selected.
[0202] Figure 8 shows the images observed on the fourth day of culture. This suggests that on the fourth day of culture, Ki67-positive and Oct3 / 4-positive undifferentiated cells with proliferation potential were present on the circular cell adhesion sites, and that aggregation sites could be formed.
[0203] Figure 9 shows images taken on the 7th day of culture. The upper image in Figure 9 shows that tissue was formed in which pluripotent Oct3 / 4-positive undifferentiated cells were mainly present in the interior, and CDX2-positive cells were present in the periphery. The lower image in Figure 9 shows that the CDX2-positive cells were Cytokeratin7-positive trophectoderm cells.
[0204] The above results suggest that in the tissue formed by culturing pluripotent stem cells on the cell culture substrate having the ring-shaped cell adhesion portion of Example 1, the portion where the cells on the periphery form a particularly dense aggregation portion is composed of trophectoderm cells, and that undifferentiated cells then infiltrate into the interior as they proliferate.
[0205] Furthermore, a cell culture substrate having a ring-shaped cell adhesion part with an inner diameter of 600 μm and a width of 100 μm was prepared under the conditions described in Example 1. Edom iPS cells were cultured on this cell culture substrate under the conditions described in Example 1. On the 9th day of culture, the cell structures adhering to the cell adhesion part of the cell culture substrate were fixed, and stained by the above procedure using an endodermal cell marker mouse IgG2a-labeled anti-E-cadherin antibody (BD Pharmingen, dilution rate 1 / 1000), a nerve cell marker rabbit IgG-labeled anti-βIII tublin antibody (Abcam, dilution rate 1 / 1000), a muscle cell marker mouse IgG2a-labeled anti-Smooth Muscle Actin antibody (SMA; Sigma, dilution rate 1 / 500), and the above secondary antibody, and then observed with a confocal microscope BZ-X710 (Keyence).
[0206] The results are shown in Figures 27 and 28. Figures 27 and 28 confirm that a sac-shaped cell structure containing E-cadherin positive cells was induced on the outer periphery, and that its interior (on the central part (non-cell adhesive part) of the ring-shaped pattern) was occupied by migrated nerve cells or muscle cells. From this, it is considered that E-cadherin positive cells that make up the outer periphery of the sac-shaped cell structure are induced on the ring-shaped cell adhesive part, and that the non-cell adhesive central part is covered by migrated nerve cells, muscle cells, etc. Furthermore, the sac-shaped cell structure seen in Figure 28 has shrunk compared to the outer dimensions of the ring-shaped cell adhesive part. This shrinkage is considered to be due to the influence of cell migration, etc.
[0207] <Example 5> In Example 1, the cells were cultured on a cell culture substrate having a ring-shaped cell adhesion part with an inner diameter of 280 μm or 380 μm and a width of 60 μm. Three to four weeks after the start of culture, the tissue that naturally detached was collected and cultured in suspension in another dish for up to six weeks after the start of culture. The tissue thus obtained had a pouch-like structure, and was evaluated by immunostaining to examine the presence or absence of intestinal cells and cells derived from the three germ layers in the tissue.
[0208] Tissues were fixed overnight using iPGell (GenoStaff) and 4% paraformaldehyde solution (Wako Pure Chemical Industries, Ltd.) according to the protocol attached to the product. The fixed tissues were embedded in paraffin and then tissue sections 4 to 6 μm thick were prepared. Antibody staining was performed as described by Uchida et al., JCI Insight Vol. 2 e86492 2017. The antibody staining method is as follows.
[0209] The tissue sections were stained with a primary antibody by incubating overnight at 4°C with rabbit IgG-labeled anti-CDX2 antibody (Abcam; dilution rate 1 / 1000) and mouse IgG-labeled anti-Villin antibody (SantaCruz Biotechnologies; dilution rate 1 / 200), or mouse IgG-labeled anti-Smooth Muscle Actin antibody (Sigma; dilution rate 1 / 500), or rabbit IgG-labeled anti-PGP9.5 antibody (DAKO; dilution rate 1 / 200). After the primary antibody staining, the tissue sections were washed three times with PBS for 5 minutes, and then incubated at room temperature for 1 hour with PBS-diluted Alexa488-labeled anti-rabbit IgG antibody and Alexa546-labeled anti-mouse IgG antibody (both Molecular Probes; dilution rate 1 / 1000) to perform secondary antibody staining. After the secondary antibody staining, the tissue sections were washed three times with PBS for 5 minutes, and then cell nuclei were stained with (DAPI; Sigma; dilution rate 1 / 1000) and mounted.
[0210] FIG. 10 shows the results of staining with anti-CDX2 antibody, anti-Villin antibody, and DAPI of the tissue formed by culturing on the cell culture substrate having a ring-shaped cell adhesion part with an inner diameter of 280 μm or 380 μm and a width of 60 μm in Example 1. The results shown in FIG. 10 show that the tissue formed in Example 1 contains intestinal epithelial tissue with a villus layer, in which the cell nuclei are CDX2 positive and the epithelium is Villin positive. FIG. 11 shows the results of staining with anti-smooth muscle actin antibody, anti-PGP9.5 antibody, and DAPI of the tissue formed by culturing on the cell culture substrate having a ring-shaped cell adhesion part with an inner diameter of 380 μm and a width of 60 μm in Example 1. The results shown in FIG. 11 show that the tissue formed in Example 1 has in addition to the intestinal epithelial tissue derived from the endoderm, smooth muscle actin-positive muscle tissue derived from the mesoderm, and PGP9.5-positive nerve fiber-like tissue derived from the ectoderm. The results shown in Figures 10 and 11 indicate that the tissue formed in Example 1 contains tissues derived from three germ layers.
[0211] <Example 6> To investigate the appropriate size and width of the circular cell adhesion region, the following analysis was performed. Cell culture substrates with ring-shaped cell adhesion regions of different inner diameters and widths were prepared in the same manner as in Example 1, and Edom iPS cells were cultured in the same manner as in Example 1. The results were visually evaluated and classified into three categories based on the state of the tissues having a pouch-like structure: ++ (tissues having a pouch-like structure were obtained efficiently), + (differentiation of tissues having a pouch-like structure occurred but there was a lot of detachment, or tissue production was slow, similar to that in Comparative Example 1), and - (tissues could not be obtained due to reasons such as cell detachment during the culture process or inability to cover the tissues due to cell proliferation).
[0212] Representative examples of observed images are shown in Figure 12. Figure 12 shows images observed on the 18th day of culture on cell culture substrates equipped with ring-shaped cell adhesion regions of various dimensions. In cases rated as "++" (left column), tissues having pouch-like structures could be detached and collected within three weeks.
[0213] The results are shown in Figure 13. Note that Figure 13 also includes the analysis results from Example 1. The results show that the inner diameter of the annular cell adhesion portion is preferably 180 µm to 880 µm, more preferably 180 µm to 600 µm, and that the width of the annular cell adhesion portion is preferably in the range of 30 µm to 400 µm, more preferably in the range of 40 µm to 400 µm, and particularly preferably 60 µm to 300 µm.
[0214] FIG. 14 shows an observed image of a tissue having a pouch-like structure obtained by culturing on a cell culture substrate having a ring-shaped cell adhesion region with an inner diameter of 580 μm and a width of 60 μm.
[0215] <Example 7> The following study was carried out regarding the shape of the cell adhesion site. The shapes of the cell adhesion sites in the cell culture substrates of the examined examples are as shown in Figures 15A, 15B, 15C, and 15D. (15A) A square with inner dimensions of 280 μm to 300 μm on each side and a cell adhesion area of 50 to 60 μm in width. (15B) A ring-shaped cell adhesion region with an inner diameter of 280 μm and a width of 60 μm, with 1 / 8 of the circumference missing. (15C) A rectangle with inner dimensions of 600 μm on the long side and 300 μm on the short side, with a cell adhesion area of 50 μm in width (15D) A square with inner dimensions of 600 μm on each side and a cell adhesion area of 50 μm in width. The method for producing the cell culture substrate and the cell culture method are as described in Example 1.
[0216] 16A, 16B, 16C, and 16D show images of cultures in which Edom iPS cells were cultured using cell culture substrates having cell adhesion parts with the shapes of (15A) to (15D) above. When using cell culture substrates having cell adhesion parts with any shape, tissues having a pouch-like structure were obtained in a short period of time, as in the other Examples. Even in the case of the ring-shaped cell adhesion part (15B), in which 1 / 8 of the circumference is missing, tissues having a pouch-like structure were formed, as in the case of a complete ring-shaped cell adhesion part over the entire circumference, because the missing part was covered by proliferated cells.
[0217] From the above results, it is clear that there is no particular limitation on the shape of the cell adhesion portion, and that it does not necessarily have to be circular. In addition, it is sufficient that the culture results in a closed system, and the initial pattern does not necessarily have to be a closed pattern. Furthermore, since intestinal structures were also obtained with rectangular cell adhesion portions surrounding the non-cell adhesion portions, it was suggested that the length and width of the non-cell adhesion portions surrounded by the cell adhesion portions do not have to be equal, and that the non-cell adhesion portions surrounded by the cell adhesion portions may be, for example, elliptical or semicircular.
[0218] <Example 8> In Example 1, the cell non-adhesive portion was formed by coating with polyethylene glycol. In this Example, it was examined whether a similar effect could be obtained by using other compounds instead of polyethylene glycol. Therefore, a cell culture substrate having a plurality of annular cell adhesive portions with an inner diameter of 280 μm or 380 μm and a width of 60 μm was prepared by the following method.
[0219] As a substrate, glass (170 μm thick) was cut into 125 mm squares, and as a pre-cleaning step, it was immersed in an alkaline cleaning solution, Parkem (Parker Corporation, PK-LCG23), for more than 48 hours, and rinsed with pure water. After that, it was irradiated with vacuum ultraviolet light (172 nm) for 6 minutes in a nitrogen atmosphere. Next, as a process for forming a circular pattern, a photosensitive dry film resist (Nichigo-Morton, NIT915) was laminated on the cleaned glass substrate on a hot plate at 100 ° C, and heated and held for 5 minutes. Then, 200 mJ of UV light (broadband) was irradiated through a photomask having an opening of the same dimensions as the circular pattern of the above dimensions. A pattern in the resist was formed by treating with a sodium carbonate aqueous solution for 2 minutes, and after baking at 100 ° C for 5 minutes, a step bake was performed at 180 ° C for 5 minutes. In this state, the substrate was cut into 15 mm x 25 mm squares, and a solution of 0.5 wt% Lipidure (registered trademark, NOF Corp.) dissolved in 99.5% ethanol was prepared separately, and about 200 μl of this solution was cast-coated onto the cut substrate. After natural drying for one day, the substrate was immersed in AZ Remover 100 (Tokyo Ohka Co., Ltd.) for 5 minutes while applying ultrasonic waves, and the resist was removed, followed by rinsing. Finally, EOG sterilization was performed for 22 hours. In this way, a substrate was obtained having a plurality of annular cell adhesion parts with an inner diameter of 280 μm or 380 μm and a width of 60 μm, where the surface of the glass substrate was exposed, and cell non-adhesive parts on the inside and outside of the annular cell adhesion parts, where the surface of the glass substrate was coated with Lipidure (registered trademark). The cell culture substrate in this example has a cross-sectional structure as shown in FIG. 1(B) similar to Example 1.
[0220] The substrate was cut into a size of 15 mm x 25 mm as in Example 1, and iPS cells were seeded thereon and examined.
[0221] The thickness of the coating of Lipidure (registered trademark) forming the cell non-adhesive portion on the substrate was measured with a step gauge and found to be 288 nm on average.
[0222] Figure 17 shows images of the cultures on each substrate on days 1, 7, and 11 of culture. The magnifications of the images on days 1 and 7 of culture are higher than that of the image on day 11 of culture. Figure 18 shows tissues with pouch-like structures obtained after three weeks of culture.
[0223] In Example 1 and the like, the surface of the substrate was coated with polyethylene glycol, a compound that inhibits cell adhesion, to form a cell non-adhesive portion. The results of this experiment show that even when a substance other than polyethylene glycol is used as a compound that inhibits cell adhesion, a cell non-adhesive portion can be formed in the same manner as with polyethylene glycol.
[0224] <Example 9> The characteristics of tissues obtained by cell culture on cell culture substrates with ring-shaped cell adhesion regions were analyzed.
[0225] The cell culture substrates used in the examples were provided with a ring-shaped pattern with an inner diameter of 180 μm and a width of 60 μm, a ring-shaped pattern with an inner diameter of 280 μm and a width of 60 μm, a ring-shaped pattern with an inner diameter of 380 μm and a width of 60 μm, a ring-shaped pattern with an inner diameter of 600 μm and a width of 100 μm, a ring-shaped pattern with an inner diameter of 600 μm and a width of 200 μm, a ring-shaped pattern with an inner diameter of 800 μm and a width of 100 μm, and a ring-shaped pattern with an inner diameter of 800 μm and a width of 200 μm, and were prepared according to the procedure described in Example 1. These substrates were used to culture Edom iPS cells according to the same procedure as in Example 1, and after 2 to 4 weeks of adhesion culture, the tissues adhered to the cell culture substrate were forcibly detached by spraying a medium, and the tissues that were subjected to suspension culture for 1 to 3 weeks after detachment were used for the following analysis.
[0226] For comparison, the tissue obtained in the above Comparative Example 1 (using a cell culture substrate with multiple circular cell adhesion parts with a diameter of 1500 μm) was analyzed in the same manner (Comparative Example 1). For further comparison, a substrate with annular cell adhesion parts with an inner diameter of 600 μm and a width of 100 μm as the cell adhesion parts and prepared by the procedure described in Example 1 was used, and Edom iPS cells were cultured in the same manner as in Example 1, and the tissue that had been attached for more than one month without natural detachment was sprayed with medium to forcibly detach it, and the tissue that had been further subjected to suspension culture for 1 to 2 weeks after detachment was analyzed in the same manner (Comparative Example 4).
[0227] After washing the tissues obtained under each condition with PBS, 900 μl of QIAzol Lysis Reagent (Qiagen) was added and the tissues were lysed using a homogenizer. Next, mRNA was extracted using RNeasy Plus Universal Mini Kit (Qiagen) and chloroform (Nacalai Tesque) according to the attached instruction manual and suspended in RNase-free water. RNA concentration and purity were measured using Nanodrop. cDNA was produced by reverse transcription using 100-200 ng of RNA and SuperScript IV VILO Master Mix (Invitrogen), and real-time quantitative PCR (qPCR) was performed according to the method described in Uchida et al., JCI Insight Vol. 2 e86492 2017. For comparison, cDNA (BioChain) derived from human small intestine (this product is not limited to a specific site, as described later) or duodenum, jejunum, and ileum was used, and 1 μl was diluted in 200 μl of UltraPure Distilled Water (Invitrogen). PCR Ready First Strand cDNA - Human Adult Normal Tissue: Small Intestine (BioChain) was used as the cDNA derived from human small intestine, which is not limited to a specific site, and PCR Ready First Strand cDNA - Human Adult Normal Tissue: Ileum (BioChain) was used as the cDNA derived from human ileum. Correction was performed using the GAPDH value, and the amounts of ABCB1 and ABCG2 in each tissue were calculated by setting the values of the amounts of ABCB1 and ABCG2 in the small intestine to 1, respectively, and the ratio of the amount of ABCG2 to the amount of ABCB1 (ABCG2 / ABCB1) was further calculated from the amounts of ABCB1 and ABCG2 calculated. Similarly, correction was performed using the GAPDH value, and the amounts of Villin and CUBN in the ileum, which expressed CUBN, were set to 1, respectively, to determine the amounts of Villin and CUBN in each tissue. From the amounts of Villin and CUBN thus determined, the ratio of the amount of CUBN to the amount of Villin (CUBN / Villin) was further calculated.
[0228] The primers used here are as follows: ABCB1 (forward primer) 5'-AAGGCCTAATGCCGAACACA-3' (SEQ ID NO: 1) ABCB1 (reverse primer) 5'-GTCTGGCCCTTCTTCACCTC-3' (SEQ ID NO: 2) ABCG2 (forward primer) 5'-GTTTATCCGTGGTGTGTCTGG-3' (SEQ ID NO: 3) ABCG2 (reverse primer) 5'-CTGAGCTATAGAGGCCTGGG-3' (SEQ ID NO: 4) Villin (forward primer) 5'-CGGAAAGCACCCGTATGGAG-3' (SEQ ID NO: 5) Villin (reverse primer) 5'-CGTCCACCACGCCTACATAG-3' (SEQ ID NO: 6) CUBN (forward primer) 5'-AATGGATGTGTGCAGCTCAG-3' (SEQ ID NO: 7) CUBN (reverse primer) 5'-GGGGTTGCTCAAACACTCAT-3' (SEQ ID NO: 8) GAPDH (forward primer) 5'-CCTGCACCACCAACTGCTTA-3' (SEQ ID NO: 9) GAPDH (reverse primer) 5'-GGCCATCCACAGTCTTCTGAG-3' (SEQ ID NO: 10)
[0229] FIG. 19 shows the average value of the ABCG2 / ABCB1 ratio under each condition. The notation in the graph means the inner diameter (unit: μm)-width (unit: μm) of the annular cell adhesion part, except for Comparative Example 1 and Comparative Example 4. The range of the ABCG2 / ABCB1 ratio in Comparative Example 1 was 0.084-3.65, and the ABCG2 / ABCB1 ratio in Comparative Example 4 was 0.44. From this result, it was suggested that the expression ratio of ABCG2 to ABCB1 was high in the tissue obtained by the present disclosure, which was detached relatively early, and that a tissue with different properties from the intestinal organoid described in Uchida et al., JCI Insight Vol. 2 e86492 2017 was obtained. In addition, it is considered that the range of the ABCG2 / ABCB1 ratio is preferably greater than 90.
[0230] Furthermore, the results of Comparative Example 4 show that if long-term adhesion culture is performed on the patterned substrate of the present disclosure, tissues equivalent to the intestinal organoids described in Uchida et al., JCI Insight Vol. 2 e86492, 2017, which have a low ABCG2 / ABCB1 ratio, can be obtained.
[0231] Furthermore, according to Uchida et al., JCI Insight Vol. 2 e86492, 2017, when human ES cells were cultured for 30 days or more in the pattern of Comparative Example 1, the amount of ABCB1 transporter was higher than the amount of ABCG2 transporter, suggesting that the ABCG2 / ABCB1 ratio was 1 or less.
[0232] FIG. 20 also shows the average values of the CUBN / Villin measurement results. This result indicates that the CUBN / Villin value is preferably in the range of 0.2 to 1.8. Note that the tissues with CUBN / Villin values in the above ranges were detached from the cell culture substrate at different times and for different periods of suspension culture, and include tissues that were detached after 2 to 4 weeks of adhesion culture and then further cultured in suspension for 1 to 3 weeks. This supports the idea that tissues with CUBN / Villin values in the above ranges are not limited to tissues with specific ranges of adhesion culture periods and suspension culture periods.
[0233] <Example 10> The following analysis was carried out on the changes in properties of areas with high cell density (aggregation areas) in tissues.
[0234] The tissue obtained in the above Comparative Example 1 using a substrate having a circular cell adhesion area with a diameter of 1500 μm was immunostained by the method described in Example 3. The primary antibodies used were mouse IgG-labeled anti-Oct3 / 4 antibody (SantaCruz Biotechnologies; dilution rate 1 / 200) as an undifferentiated marker, and rabbit IgG-labeled anti-Ki67 antibody (Abcam; dilution rate 1 / 500) as a cell proliferation marker.
[0235] The results are shown in Figure 21. This result suggests that the expression of undifferentiated cells is reduced in areas of high cell density (aggregation areas) in the tissue.
[0236] The following study was also conducted to examine whether there were any differences depending on the container. Edom iPS cells were seeded on a 3.5 cm diameter cell culture dish (culture dish), a glass substrate without a pattern (both 1.5 cm × 2.5 cm in size) (plain glass), and a substrate with a circular cell adhesion area with a diameter of 1500 μm (patterned substrate), and cultured in the same manner as in Example 1. In order to standardize the cell density, the cell culture dish was seeded with 5 × 10 6 cells were seeded.
[0237] After culturing on each of the above substrates for 7 days, immunostaining was performed according to the method described in Example 4. The primary antibody used here was a mouse IgG-labeled anti-CDX2 antibody (Biogenex; dilution rate 1 / 500), and the secondary antibody was an Alexa546-labeled anti-mouse IgG antibody. Cell nuclei were stained with DAPI.
[0238] The results are shown in Figure 22. This result suggests that CDX2-positive trophectoderm cells were differentiated in the areas with high cell density (aggregation areas) in the formed tissue, regardless of the type of substrate.
[0239] <Example 11> Genetic analysis was carried out in connection with the analysis in Example 9. FIG. 23 shows an observation image of the tissue on the 7th day of culture when Edom iPS cells were cultured on the substrate having a circular cell adhesion part with a diameter of 1500 μm in Comparative Example 1 by the procedure of Example 1. The aggregation part refers to the part of the tissue adhered to the cell adhesion part where cells are densely packed, surrounded by an ellipse in the left photograph of FIG. 23. The non-aggregation part refers to the part of the tissue adhered to the cell adhesion part where cells are not densely packed, as shown in the right photograph of FIG. 23 (in the case of the right photograph of FIG. 23, the entire tissue is the non-aggregation part). Cells of the aggregation part and cells of the non-aggregation part were collected from the tissue on the 7th day of culture using a glass capillary. RNA was obtained from each sample of cells of the aggregation part and cells of the non-aggregation part using RNeasy Plus Mini Kit (Qiagen) and suspended in RNase-Free water. RNA concentration and purity were measured using NanoDrop (trademark, Thermo Fisher Scientific). cDNA was prepared by reverse transcription using 100-200 ng of RNA and SuperScript IV VILO Master Mix (Invitrogen), and real-time quantitative PCR (qPCR) was performed as described in Uchida et al., JCI Insight Vol. 2 e86492 2017 and Example 9.
[0240] The primers used here are as follows: Oct3 / 4 (forward primer) 5'-CGAGGAATTTGCCAAGCTCTGA-3' (SEQ ID NO: 11) Oct3 / 4 (reverse primer) 5'-TTCGGGCACTGCAGGAACAAATTC-3' (SEQ ID NO: 12) GAPDH (forward primer) 5'-CCTGCACCACCAACTGCTTA-3' (same as SEQ ID NO: 9) GAPDH (reverse primer) 5'-GGCCATCCACAGTCTTCTGAG-3' (same as SEQ ID NO: 10)
[0241] For each sample from the aggregated and non-aggregated parts, the expression level of Oct3 / 4 was calculated as a corrected value corrected by the expression level of GAPDH. Then, the expression level of Oct3 / 4 in the aggregated part sample was calculated as a relative value when the expression level of Oct3 / 4 in the non-aggregated part sample was set to 1.
[0242] The results are shown in the graph of Figure 24. This result suggests that the expression of the undifferentiated marker Oct3 / 4 gene is significantly reduced in the condensed areas compared to the non-condensed areas. This result indicates that when pluripotent stem cells are cultured on a substrate with cell adhesion areas, the expression of the undifferentiated marker Oct3 / 44 gene is reduced in the condensed areas formed by cells densely adhering to the cell adhesion areas, and they are more likely to become trophectoderm cells.
[0243] Furthermore, the characteristics of the aggregates of pluripotent stem cell cultures observed in Examples 10 and 11 are characteristics common to the aggregates formed by densely packing pluripotent stem cells during culture, and therefore it is believed that the aggregates formed by densely packing pluripotent stem cells at the annular cell adhesion sites also have similar characteristics.
[0244] <Example 12> To investigate the properties of epithelial cells in the obtained intestinal organoids, the following analyses were performed. On a cell culture substrate with multiple circular cell adhesion parts with an inner diameter of 580 μm and a width of 60 μm prepared in the same manner as in Example 1, and a cell culture substrate with multiple circular cell adhesion parts with a diameter of 1500 μm prepared in Comparative Example 1, Edom iPS cells were cultured in the same manner as in Example 1 to prepare a pouch-shaped tissue (intestinal organoid). Using the obtained tissue, immunostaining was performed by the method described in the same manner as in Example 5 above. As antibodies, mouse IgG1-labeled anti-Cytokeratin7 antibody (KRT7; Abcam, dilution rate 1 / 500) and rabbit IgG-labeled anti-CDX2 antibody used in Example 4 above were used. The same secondary antibody as in Example 4 was used, and cell nuclei were stained with DAPI.
[0245] The results are shown in Figure 25. As shown in Figure 25, CDX2-positive cells in the epithelial cells of the pouch-like tissue also expressed KRT7. Furthermore, this property was not dependent on the pattern shape, and it was suggested that it was derived from CDX2-positive trophectoderm cells seen in the condensation areas inside the pattern.
[0246] <Example 13> To investigate whether neurons migrate from cell aggregates formed during culture on a cell culture substrate equipped with a pattern of cell adhesion sites, the following analysis was performed.
[0247] Edom iPS cells were cultured under the same conditions as in Example 1. However, as the cell culture substrate, the cell culture substrate having multiple circular cell adhesion areas with a diameter of 1500 μm used in Comparative Example 1 was used, taking into consideration the ease of recovery work and the ease of distinguishing between aggregated and non-aggregated areas.
[0248] One week and two weeks after the start of the culture, the culture was observed under a stereomicroscope, and the formed cell aggregates were collected using a glass capillary and an appropriate number of clumps were reseeded in a Vitronectin-coated 3.5 cm diameter culture dish (AGC). The XF hESC culture medium described in Non-Patent Document 3 was used as the medium, as in Example 1. The culture was then maintained for several days, after which the nerve cells were identified by immunostaining.
[0249] The staining method was the same as in Example 4. The primary antibodies used were mouse IgG1-labeled anti-Nestin antibody (Sigma, dilution ratio 1 / 500) and rabbit IgG-labeled anti-βIII tublin antibody (Abeam, dilution ratio 1 / 1000).
[0250] The aggregates were collected one week after the start of the culture, and then cultured again for four days. The results of immunostaining of the culture are shown in Figure 29. Cells positive for neural markers were observed on the periphery of the aggregates. This suggests that neural cells are generated from the aggregates.
[0251] The results of immunostaining of the cultured material, which was collected two weeks after the start of culture and then cultured again for one day, are shown in Figure 30. It was suggested that at this point, the aggregate contained highly migratory nerve cells. It is presumed that the highly migratory nerve cells could spread and cover the non-cell-adhesive area (center).
[0252] <Example 14> The following study was carried out in order to find conditions under which the cells and pouch-like cell structures obtained on the cell culture substrate would be maintained in an adhered state on the substrate without detachment. Using a cell culture substrate having a plurality of ring-shaped cell adhesion sites with an inner diameter of 600 μm and a width of 100 μm produced by the method described in Example 1, Edom iPS cells were cultured under the same conditions as in Example 1. On day 11 after the start of culture, the cells were replaced with XF hESC medium described in Non-Patent Document 3 (control, the same as up to day 11), Hank's buffered solution containing calcium ions and magnesium ions (HBSS(+), Nacalai Tesque), medium obtained by removing the nutrient factors bFGF, hereglin, and IGF-1 from the XF hESC medium (GF(-) medium), and medium obtained by removing the nutrient factors from the XF hESC medium and adding 1% XF-KSR (Knockout Serum Replacement XF CTS (XF-KSR; Life Technologies)) (1% XF-KSR medium), and the cells were then continued to be cultured, and photographs were taken after appropriate observations.
[0253] Figure 31 shows an image of the culture after 4 days of culture following replacement of the medium, and Figure 32 shows an image of the culture after 10 days of culture following replacement of the medium. Cell detachment was observed in HBSS(+), making it unsuitable, whereas in the medium from which nutritional factors were removed (GF(-) and 1% XF-KSR), small pouch-like structures and cells were confirmed to be maintained in an attached state on the cell culture area of the cell culture substrate. In the control, pouch-like structures of normal size and shape were observed at the stage shown in Figure 32, 3 weeks after the start of culture, and the culture itself is considered to have been normal.
[0254] Furthermore, when the culture was continued further, spontaneous detachment of the sac-like cell structures and associated cells was observed in the control, whereas in the medium from which nutritional factors were removed (GF(-) and 1% XF-KSR), the adhesion state of the cells and sac-like cell structures was observed to be maintained. This suggests that in the medium from which nutritional factors were removed, the sac-like cell structures can be maintained in an adherent state on the cell culture substrate, and that the cells and tissues within the cell structures are maintained.
[0255] All publications, patents, and patent applications cited herein are hereby incorporated by reference in their entirety.
Claims
1. A pouch-shaped cell structure containing small intestinal epithelial cells and having a villi layer on its outer surface, when the expression levels of the ABCG2 transporter and the ABCB1 transporter in the sac-like cell structure are expressed as relative values to the expression levels of the ABCG2 transporter and the ABCB1 transporter in the small intestinal tissue of the source animal, respectively, the relative value of the expression level of the ABCG2 transporter in the sac-like cell structure is 90 times or more higher than the relative value of the expression level of the ABCB1 transporter; A pouch-like cellular structure containing small intestinal epithelial cells and having a villi layer on its outer surface.
2. The sac-shaped cell structure according to claim 1 , wherein the expression levels are based on the amount of mRNA.
3. The pouch-like cell structure according to claim 1 or 2, wherein the small intestinal epithelial cells express Cytokeratin 7.
4. The pouch-shaped cell structure according to any one of claims 1 to 3, comprising endodermal cells, ectodermal cells and mesodermal cells.
5. The sac-shaped cell structure is A cell culture substrate having a surface including a first non-cell-adhesive portion and a cell culture portion disposed in the first non-cell-adhesive portion, the cell culture portion includes a second cell non-adhesive portion and a cell adhesive portion that extends continuously or intermittently through one or more interruptions along the periphery of the second cell non-adhesive portion and surrounds the second cell non-adhesive portion, and no cell adhesive portion is present in the second cell non-adhesive portion; The length of each of the one or more interrupted portions is equal to or less than one-sixth of the total circumference of the second non-cell-adhesive portion, and the total length of the one or more interrupted portions is equal to or less than one-sixth of the total circumference of the second non-cell-adhesive portion. Seeding stem cells onto a cell culture substrate; and The pouch-like cell structure described in any one of claims 1 to 4, which is produced by a method for producing a pouch-like cell structure containing small intestinal epithelial cells and having a villus layer on its outer surface, the method comprising culturing the seeded stem cells and differentiating a portion of the stem cells into small intestinal epithelial cells.
6. A sac-shaped cell structure as described in claim 5, wherein in the method, the distance between a straight line passing through the midpoint of the two most distant points opposing each other on the inner circumference of the cell adhesive portion via the second cell non-adhesive portion and two intersection points with the inner circumference of the cell adhesive portion is greater than 80 μm and less than 880 μm.
7. A bag-like cell structure as described in claim 5 or 6, wherein, in the method, the width of the cell adhesive portion in a direction along a straight line passing through the midpoint of the two most distant points opposing each other via the second cell non-adhesive portion on the inner circumference of the cell adhesive portion is more than 30 μm and less than 400 μm.
8. A cell structure-holding substrate comprising the pouch-shaped cell structure according to any one of claims 1 to 7.
9. A test kit comprising the pouch-like cell structure according to any one of claims 1 to 7.
10. A test method, comprising using the pouch-like cell structure according to any one of claims 1 to 7.
Citation Information
Patent Citations
JP1975070565A
High temperature lubricant
JP1986051097A
Production of sic whisker
JP1987096399A
Cell culture substrate
JP2012120443A
Electrode-attached cell testing tool
JP2013179910A
